data_2hh2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hh2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.638 ' CD1' ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.624 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.663 HD12 HG12 ' A' ' 73' ' ' ILE . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.544 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB3' HD21 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HE2' HG21 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 84' ' ' VAL . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.756 HG21 HG13 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.479 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.669 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.583 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.463 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.662 HD11 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.734 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 12' ' ' SER . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.47 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' O ' HD13 ' A' ' 72' ' ' LEU . 10.5 t-160 -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.669 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.542 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 HD11 HG23 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.789 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.645 HD11 HG21 ' A' ' 21' ' ' VAL . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.701 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.721 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.67 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 21.9 t-20 -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.67 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.721 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.7 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.613 HG22 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.547 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.789 HG23 HG12 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.546 HG23 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' HD13 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.472 ' CB ' HG23 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.462 HG21 HD12 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.404 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.755 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 HG21 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.755 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.631 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.407 HD12 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.472 HG23 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.715 HD12 HG21 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.416 ' HB2' HG22 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.513 HG22 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.95 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.657 ' CD1' ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HA ' HD13 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.696 HG22 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.486 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.492 HH11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HE2' HG22 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.516 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.95 HG23 HG13 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.521 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.602 ' HB3' HG21 ' A' ' 58' ' ' ILE . 2.2 mp0 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.491 0.186 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.451 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 13.6 p80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HZ3' ' HB ' ' A' ' 77' ' ' ILE . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 HG23 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.946 HG12 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HA ' HG12 ' A' ' 29' ' ' VAL . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 22' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.607 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 21.1 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.946 HG21 HG12 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.614 ' HB ' ' HZ3' ' A' ' 17' ' ' LYS . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.57 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.668 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.739 ' HB3' HD11 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.401 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.554 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.689 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.93 HG13 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.626 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 28' ' ' ASN . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.3 t-20 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 56' ' ' LEU . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.639 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.44 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.668 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.596 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.624 HD13 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.93 HG23 HG13 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.775 HG22 HD12 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 19.2 p80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.611 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.65 HD11 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.948 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.732 ' HA ' HG12 ' A' ' 29' ' ' VAL . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.772 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.948 HG23 HG12 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.509 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.426 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.836 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.964 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.747 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.6 m-80 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 1.006 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 1.006 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' CE2' HG12 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' O ' HD13 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.964 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.626 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.562 HG23 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.741 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.976 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.505 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.9 OUTLIER -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.715 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.585 HD11 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.976 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.609 HG22 HD13 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.644 HD13 HG23 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.764 HG13 ' HE1' ' A' ' 57' ' ' PHE . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' NE2' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.489 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.485 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.764 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.581 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.65 ' NE2' ' HA3' ' A' ' 37' ' ' GLY . 9.7 mm100 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' HD11 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.845 HE21 ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.925 HG21 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.68 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.673 ' HB2' HG22 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.82 HG23 HD13 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.705 HD13 HG21 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 1.065 HG11 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 HG23 ' A' ' 13' ' ' ILE . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.706 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.569 HG23 HD13 ' A' ' 72' ' ' LEU . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 16.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.61 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 49' ' ' ASN . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 47' ' ' PRO . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.065 HG22 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.705 HG21 HD13 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.707 ' HE2' ' HB3' ' A' ' 83' ' ' PRO . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 19' ' ' GLY . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.678 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' CA ' HG21 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.678 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.725 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.887 HE21 ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.401 ' CB ' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' HB ' HG22 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.587 ' O ' HD13 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.616 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 20' ' ' LEU . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.55 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HB3' ' HE2' ' A' ' 9' ' ' MET . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.642 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.722 ' HB2' HG22 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.529 HG23 HD13 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.637 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD13 HG23 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.976 HG13 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.642 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 72' ' ' LEU . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.651 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.585 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HG13 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.502 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.8 HD11 HG23 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.753 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.65 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.1 m-80 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.747 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 28' ' ' ASN . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.441 HG21 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' LEU . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.595 ' HD3' HD23 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.498 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.642 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 9.3 mm100 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.642 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.581 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.516 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.749 ' HA ' HG12 ' A' ' 29' ' ' VAL . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.584 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.432 ' CB ' HD12 ' A' ' 56' ' ' LEU . 46.4 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HD2' HG21 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HB ' ' HZ1' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.549 ' CD2' ' HB3' ' A' ' 14' ' ' PRO . 24.0 p80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.608 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.811 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.759 ' HA ' HG23 ' A' ' 29' ' ' VAL . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 28' ' ' ASN . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 15.3 mm100 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.694 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.401 ' HB2' HD11 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 HG11 ' A' ' 84' ' ' VAL . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.466 HD13 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 24.8 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.638 ' O ' HD13 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HZ2' ' CD ' ' A' ' 74' ' ' GLU . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.811 HG23 HG12 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB2' HG11 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.535 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HA ' HD21 ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.753 HD12 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' HG12 ' A' ' 29' ' ' VAL . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.657 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.632 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.632 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.577 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.541 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.753 HG22 HD12 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.706 ' HB3' HG23 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HD12 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 17.8 p80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.711 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.63 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.489 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.426 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.693 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' HD13 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.946 HG22 HG13 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.711 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.634 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 13' ' ' ILE . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.743 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.1 t-20 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 2.7 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.474 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.573 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.474 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.661 HG21 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.728 ' HB2' HG12 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.534 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.435 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.98 137.23 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.756 HG13 HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.638 ' CD1' ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.624 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.663 HD12 HG12 ' A' ' 73' ' ' ILE . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.491 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.544 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB3' HD21 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HE2' HG21 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 84' ' ' VAL . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.465 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.756 HG21 HG13 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.641 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.479 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.01 131.79 48.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.669 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.583 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.463 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.667 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.662 HD11 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.734 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 12' ' ' SER . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.47 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.669 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' O ' HD13 ' A' ' 72' ' ' LEU . 10.5 t-160 -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.669 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.542 HG23 HD13 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 -73.07 141.68 47.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.667 -0.267 . . . . 0.0 110.377 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.542 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.546 HD11 HG23 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.789 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.645 HD11 HG21 ' A' ' 21' ' ' VAL . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.611 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.611 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.701 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.721 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.604 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.67 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 21.9 t-20 -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.67 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.613 ' HB ' HG22 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.721 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.7 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.613 HG22 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.547 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.701 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.789 HG23 HG12 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.546 HG23 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' HB ' HD13 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.96 125.05 25.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.472 ' CB ' HG23 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.462 HG21 HD12 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.404 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.755 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.667 HD13 HG21 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.755 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.631 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.407 HD12 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.467 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.472 HG23 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.715 HD12 HG21 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.667 HG21 HD13 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.89 114.83 3.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.416 ' HB2' HG22 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.513 HG22 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.95 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.657 ' CD1' ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.589 ' HA ' HD13 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.696 HG22 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.486 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.492 HH11 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.513 ' HE2' HG22 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.516 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.652 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG22 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.95 HG23 HG13 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.521 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.602 ' HB3' HG21 ' A' ' 58' ' ' ILE . 2.2 mp0 -92.91 117.46 30.07 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.809 -0.23 . . . . 0.0 110.936 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.451 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.426 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 13.6 p80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HZ3' ' HB ' ' A' ' 77' ' ' ILE . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD13 HG23 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG12 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.568 ' HA ' HG12 ' A' ' 29' ' ' VAL . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 22' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.46 HG23 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.602 HG21 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.607 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 21.1 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.946 HG21 HG12 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.614 ' HB ' ' HZ3' ' A' ' 17' ' ' LYS . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.57 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.546 ' O ' HD13 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.699 -0.16 . . . . 0.0 112.699 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 -93.68 88.42 5.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.668 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.739 ' HB3' HD11 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.401 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.554 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.689 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.775 HD12 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.93 HG13 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.626 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 28' ' ' ASN . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.3 t-20 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.639 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 56' ' ' LEU . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.639 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.44 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.668 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.596 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.624 HD13 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.93 HG23 HG13 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.775 HG22 HD12 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.16 128.08 36.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 19.2 p80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.611 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.65 HD11 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.948 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.732 ' HA ' HG12 ' A' ' 29' ' ' VAL . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.678 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.772 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.948 HG23 HG12 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.509 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.772 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.426 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.501 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -90.12 142.66 27.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.566 HG22 ' CD1' ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.836 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.964 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.747 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.6 m-80 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG11 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.446 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 1.006 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.422 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 1.006 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' CE2' HG12 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.48 HG22 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' O ' HD13 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.964 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.54 ' O ' HD12 ' A' ' 66' ' ' ILE . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 -94.47 83.99 4.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.626 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.562 HG23 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.741 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.609 HD13 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.976 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.505 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 49' ' ' ASN . 0.9 OUTLIER -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.715 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.585 HD11 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.976 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.609 HG22 HD13 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 -90.44 116.29 28.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.414 HG23 ' CD1' ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.629 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.644 HD13 HG23 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.925 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.764 HG13 ' HE1' ' A' ' 57' ' ' PHE . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.681 HG11 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.752 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' HA3' ' NE2' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.555 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.485 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.764 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.581 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.65 ' NE2' ' HA3' ' A' ' 37' ' ' GLY . 9.7 mm100 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' O ' HD11 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.845 HE21 ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.925 HG21 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.478 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 120.909 0.172 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.68 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 -91.48 144.86 25.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.673 ' HB2' HG22 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.82 HG23 HD13 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.525 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.705 HD13 HG21 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 1.065 HG11 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.82 HD13 HG23 ' A' ' 13' ' ' ILE . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.706 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.569 HG23 HD13 ' A' ' 72' ' ' LEU . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 16.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 49' ' ' ASN . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 47' ' ' PRO . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.643 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.065 HG22 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.705 HG21 HD13 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.11 134.05 35.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.707 ' HE2' ' HB3' ' A' ' 83' ' ' PRO . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' HG23 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 19' ' ' GLY . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.678 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' CA ' HG21 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.678 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.725 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.887 HE21 ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.716 HG23 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' CB ' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.658 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' HB ' HG22 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG22 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.587 ' O ' HD13 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.716 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.616 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 20' ' ' LEU . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.55 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HB3' ' HE2' ' A' ' 9' ' ' MET . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.642 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.45 136.16 33.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.722 ' HB2' HG22 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.529 HG23 HD13 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.535 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.637 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD13 HG23 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.976 HG13 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.642 ' HA ' HG13 ' A' ' 29' ' ' VAL . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.642 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.587 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.551 HG23 HD13 ' A' ' 72' ' ' LEU . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.41 HG23 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.651 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.585 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.585 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.651 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.722 HG22 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.595 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.976 HG21 HG13 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 113.291 0.077 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -85.3 167.46 15.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.73 ' HB2' HG23 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.581 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.715 HG21 HD12 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.502 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.8 HD11 HG23 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.953 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.753 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.65 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.1 m-80 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.747 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 28' ' ' ASN . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.498 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG21 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 46' ' ' LEU . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.595 ' HD3' HD23 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD23 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' CE2' HG12 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.498 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.642 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 9.3 mm100 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.73 HG23 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.642 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.662 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.953 HG21 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.581 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' HD13 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.38 -0.122 . . . . 0.0 113.059 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 -91.93 143.4 26.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.516 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.486 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HZ1' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.749 ' HA ' HG12 ' A' ' 29' ' ' VAL . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.584 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.416 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.479 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' CB ' HD12 ' A' ' 56' ' ' LEU . 46.4 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' HD2' HG21 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.647 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HB ' ' HZ1' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 128.59 36.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.543 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.549 ' CD2' ' HB3' ' A' ' 14' ' ' PRO . 24.0 p80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.608 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.811 HG12 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.759 ' HA ' HG23 ' A' ' 29' ' ' VAL . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.593 HG13 ' O ' ' A' ' 28' ' ' ASN . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 15.3 mm100 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.694 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.412 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.401 ' HB2' HD11 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 HG11 ' A' ' 84' ' ' VAL . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 HD13 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 24.8 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.638 ' O ' HD13 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HZ2' ' CD ' ' A' ' 74' ' ' GLU . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.811 HG23 HG12 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.67 ' HB2' HG11 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.535 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HA ' HD21 ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 -91.91 100.92 13.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.753 HD12 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' HG12 ' A' ' 29' ' ' VAL . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.553 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.657 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.632 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.632 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.577 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.541 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.753 HG22 HD12 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 -64.65 118.82 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 176.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.706 ' HB3' HG23 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.472 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.871 HG22 HD12 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.58 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 17.8 p80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.711 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.63 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.946 HG13 HG22 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.721 HG22 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.462 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.591 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.426 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.693 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.706 HG23 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' HD13 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.946 HG22 HG13 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.711 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -63.94 111.96 2.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 57' ' ' PHE . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.752 HG23 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.634 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.619 HD11 HG21 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.825 HG13 HG21 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.752 HD11 HG23 ' A' ' 13' ' ' ILE . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.743 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.1 t-20 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 2.7 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.474 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.573 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.661 ' HB ' HG21 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.661 HG21 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.708 ' HA ' HG22 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.825 HG21 HG13 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.728 ' HB2' HG12 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 HG22 HD13 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.534 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.435 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 22' ' ' ILE . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HA ' HD21 ' A' ' 20' ' ' LEU . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.085 ' HA ' HD13 ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.085 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 29' ' ' VAL . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG12 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 58' ' ' ILE . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HE2' HG23 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 45' ' ' GLN . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.649 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.776 HG23 HG11 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 81' ' ' LEU . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.567 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.667 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' HE2' ' A' ' 55' ' ' LYS . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.098 ' HA ' HD13 ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.039 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.098 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.773 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 15' ' ' THR . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 84' ' ' VAL . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.667 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.578 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.039 HG23 HG11 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.579 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.858 HG21 HD11 ' A' ' 22' ' ' ILE . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 14' ' ' PRO . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.03 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD11 HG22 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.03 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.71 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.751 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.589 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.553 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.616 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.679 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 36.9 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.833 HG23 HG11 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.552 HG22 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.462 ' CB ' HG21 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.052 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.052 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.776 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.745 HG23 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.64 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.64 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.487 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 74' ' ' GLU . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.745 HD12 HG23 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.984 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.424 ' HB2' HG21 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 22' ' ' ILE . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.576 HG23 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.076 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.076 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HE2' HG23 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG23 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 73' ' ' ILE . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.627 ' HB3' HG23 ' A' ' 58' ' ' ILE . 2.2 mp0 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.491 0.186 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.457 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.569 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 22' ' ' ILE . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.947 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.973 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.624 ' HA ' HD12 ' A' ' 32' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.428 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 53.4 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.973 HG23 HG11 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 20' ' ' LEU . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.681 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.767 ' HB3' HD12 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.828 HD11 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.637 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 6.4 t30 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.687 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.607 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.651 HD12 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.939 HG23 HG11 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.828 HG22 HD11 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.023 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.96 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.023 HD13 ' HA ' ' A' ' 18' ' ' CYS . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.691 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.602 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.96 HG23 HG11 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG21 HD11 ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.998 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.857 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.992 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.998 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 21.6 m120 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' O ' HD13 ' A' ' 56' ' ' LEU . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.94 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.94 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.992 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.545 HG21 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.073 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.649 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.987 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.073 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.534 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.725 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.604 ' O ' HD12 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.987 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.482 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.629 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.756 HG21 HD11 ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.616 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.994 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 HG22 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.994 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 32' ' ' ILE . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.763 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.511 ' HA3' ' OE1' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.568 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.768 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.779 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.511 ' OE1' ' HA3' ' A' ' 37' ' ' GLY . 9.8 mm-40 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' O ' HD12 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.954 HG23 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 81' ' ' LEU . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 10' ' ' THR . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.719 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.684 ' HB2' HG21 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.931 ' HA ' HD13 ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.075 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' H ' ' A' ' 27' ' ' GLU . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.603 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.444 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.075 HG23 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.435 ' HB3' HG21 ' A' ' 66' ' ' ILE . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB3' HG21 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 22' ' ' ILE . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 16' ' ' HIS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.016 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.016 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.719 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.7 mm-40 -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.723 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.667 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.546 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.41 ' HB2' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.667 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 79' ' ' GLY . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.741 ' HB2' HG21 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HZ1' HD12 ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.933 ' HA ' HD13 ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.419 HG21 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.657 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.644 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.741 HG21 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.58 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.995 HG23 HG11 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.74 ' HB2' HG21 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.483 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.037 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.958 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.037 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 32' ' ' ILE . 21.0 m120 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 29' ' ' VAL . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.573 ' HD3' HD21 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 53' ' ' ASN . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.523 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 55.6 mm-40 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.74 HG21 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.958 HG23 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.588 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.514 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 22' ' ' ILE . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.584 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.01 ' HA ' HD13 ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.647 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.01 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.635 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.555 ' HB2' HD12 ' A' ' 56' ' ' LEU . 50.8 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HD2' HG23 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 45' ' ' GLN . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.659 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.647 HG23 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.584 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 22' ' ' ILE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.982 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.982 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 29' ' ' VAL . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.6 mm-40 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 45' ' ' GLN . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 68.4 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.649 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.813 HG23 HG11 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.694 ' HB2' HG13 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 22' ' ' ILE . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 1.032 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.772 HD11 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.032 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.642 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.008 HG23 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.727 ' HB3' HG21 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HD11 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HG2' HD21 ' A' ' 20' ' ' LEU . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.809 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.937 HD11 HG21 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 29' ' ' VAL . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.72 HG21 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.707 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' HD12 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.974 HG23 HG11 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG22 HD11 ' A' ' 20' ' ' LEU . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 1.4 pm0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.86 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 8.4 t30 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.1 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 56' ' ' LEU . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 45' ' ' GLN . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 8' ' ' GLU . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.86 HG23 HG11 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HB2' HG13 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.575 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.98 137.23 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 22' ' ' ILE . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HA ' HD21 ' A' ' 20' ' ' LEU . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.085 ' HA ' HD13 ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.085 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 29' ' ' VAL . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG12 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 58' ' ' ILE . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HE2' HG23 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 45' ' ' GLN . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.649 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.776 HG23 HG11 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 81' ' ' LEU . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.567 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.01 131.79 48.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.667 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' HE2' ' A' ' 55' ' ' LYS . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.098 ' HA ' HD13 ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.039 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.098 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.773 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 15' ' ' THR . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 84' ' ' VAL . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.667 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.578 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.039 HG23 HG11 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 -73.07 141.68 47.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.667 -0.267 . . . . 0.0 110.377 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.579 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.858 HG21 HD11 ' A' ' 22' ' ' ILE . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 14' ' ' PRO . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.03 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD11 HG22 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.03 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.71 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.751 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.589 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.553 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.616 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.679 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 36.9 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.833 HG23 HG11 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.552 HG22 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.96 125.05 25.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.462 ' CB ' HG21 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.052 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.052 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.776 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.745 HG23 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.64 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.64 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.487 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 74' ' ' GLU . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.745 HD12 HG23 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.984 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.89 114.83 3.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.424 ' HB2' HG21 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 22' ' ' ILE . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.576 HG23 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.076 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.076 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HE2' HG23 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG23 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 73' ' ' ILE . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.627 ' HB3' HG23 ' A' ' 58' ' ' ILE . 2.2 mp0 -92.91 117.46 30.07 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.809 -0.23 . . . . 0.0 110.936 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.457 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.569 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 22' ' ' ILE . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.947 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.973 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.624 ' HA ' HD12 ' A' ' 32' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.428 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 53.4 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.973 HG23 HG11 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 20' ' ' LEU . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.699 -0.16 . . . . 0.0 112.699 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 -93.68 88.42 5.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.681 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.767 ' HB3' HD12 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.828 HD11 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.637 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 6.4 t30 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.687 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.607 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.651 HD12 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.939 HG23 HG11 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.828 HG22 HD11 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.16 128.08 36.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.023 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.96 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.023 HD13 ' HA ' ' A' ' 18' ' ' CYS . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.691 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.602 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.96 HG23 HG11 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -90.12 142.66 27.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG21 HD11 ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.998 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.857 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.992 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.998 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 21.6 m120 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' O ' HD13 ' A' ' 56' ' ' LEU . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.94 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.94 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.992 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 -94.47 83.99 4.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.545 HG21 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.073 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.649 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.987 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.073 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.534 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.725 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.604 ' O ' HD12 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.987 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.482 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.629 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 -90.44 116.29 28.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.756 HG21 HD11 ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.616 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.994 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 HG22 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.994 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 32' ' ' ILE . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.763 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.511 ' HA3' ' OE1' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.568 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.768 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.779 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' OE1' ' HA3' ' A' ' 37' ' ' GLY . 9.8 mm-40 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' O ' HD12 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.954 HG23 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 81' ' ' LEU . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 10' ' ' THR . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 120.909 0.172 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.719 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 -91.48 144.86 25.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.684 ' HB2' HG21 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.931 ' HA ' HD13 ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.075 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' H ' ' A' ' 27' ' ' GLU . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.603 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.444 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.075 HG23 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.11 134.05 35.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.435 ' HB3' HG21 ' A' ' 66' ' ' ILE . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB3' HG21 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 22' ' ' ILE . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 16' ' ' HIS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.016 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.016 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.719 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.7 mm-40 -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.723 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.667 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.546 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' HB2' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.667 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 79' ' ' GLY . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.45 136.16 33.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.741 ' HB2' HG21 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HZ1' HD12 ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.933 ' HA ' HD13 ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.419 HG21 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.657 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.644 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.741 HG21 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.58 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.995 HG23 HG11 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 113.291 0.077 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -85.3 167.46 15.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.74 ' HB2' HG21 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.483 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.037 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.958 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.037 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 32' ' ' ILE . 21.0 m120 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 29' ' ' VAL . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.573 ' HD3' HD21 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 53' ' ' ASN . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.523 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 55.6 mm-40 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.74 HG21 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.958 HG23 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.588 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.38 -0.122 . . . . 0.0 113.059 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 -91.93 143.4 26.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.514 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 22' ' ' ILE . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.584 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.01 ' HA ' HD13 ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.647 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.01 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.635 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.555 ' HB2' HD12 ' A' ' 56' ' ' LEU . 50.8 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HD2' HG23 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 45' ' ' GLN . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.659 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.647 HG23 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.584 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 128.59 36.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 22' ' ' ILE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.982 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.982 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 29' ' ' VAL . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.6 mm-40 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 45' ' ' GLN . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 68.4 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.649 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.813 HG23 HG11 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.694 ' HB2' HG13 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 -91.91 100.92 13.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 22' ' ' ILE . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 1.032 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.772 HD11 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.032 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.642 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.008 HG23 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 -64.65 118.82 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 176.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.727 ' HB3' HG21 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HD11 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HG2' HD21 ' A' ' 20' ' ' LEU . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.809 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.937 HD11 HG21 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 29' ' ' VAL . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.72 HG21 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.707 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' HD12 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.974 HG23 HG11 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG22 HD11 ' A' ' 20' ' ' LEU . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 1.4 pm0 -63.94 111.96 2.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.86 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 8.4 t30 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.1 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 56' ' ' LEU . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 45' ' ' GLN . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 8' ' ' GLU . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.86 HG23 HG11 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HB2' HG13 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.575 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 22' ' ' ILE . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HA ' HD21 ' A' ' 20' ' ' LEU . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.085 ' HA ' HD13 ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.085 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 29' ' ' VAL . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG12 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 58' ' ' ILE . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HE2' HG23 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 45' ' ' GLN . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.649 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.776 HG23 HG11 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 81' ' ' LEU . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.567 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.667 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' HE2' ' A' ' 55' ' ' LYS . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.098 ' HA ' HD13 ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.039 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.098 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.773 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 15' ' ' THR . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 84' ' ' VAL . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.667 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.578 ' O ' HD12 ' A' ' 72' ' ' LEU . 10.5 t-160 -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.039 HG23 HG11 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.579 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.858 HG21 HD11 ' A' ' 22' ' ' ILE . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 14' ' ' PRO . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.03 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD11 HG22 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.833 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.03 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.71 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.751 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.589 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.553 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 21.9 t-20 -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.616 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.679 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 13.7 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.833 HG23 HG11 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.552 HG22 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.462 ' CB ' HG21 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.052 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.052 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.776 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.745 HG23 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.64 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.64 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.487 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.436 ' NE2' ' H ' ' A' ' 64' ' ' GLN . 1.8 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 74' ' ' GLU . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.745 HD12 HG23 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.984 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.424 ' HB2' HG21 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 22' ' ' ILE . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.576 HG23 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.076 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.076 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HE2' HG23 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG23 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 73' ' ' ILE . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.627 ' HB3' HG23 ' A' ' 58' ' ' ILE . 2.2 mp0 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 120.491 0.186 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.457 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.569 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 22' ' ' ILE . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.455 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 13.6 p80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.947 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.973 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.624 ' HA ' HD12 ' A' ' 32' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.428 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 21.1 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.973 HG23 HG11 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 20' ' ' LEU . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.681 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.767 ' HB3' HD12 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.828 HD11 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.637 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.3 t-20 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.687 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.607 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.651 HD12 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.939 HG23 HG11 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.828 HG22 HD11 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.455 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 19.2 p80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.023 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.96 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.023 HD13 ' HA ' ' A' ' 18' ' ' CYS . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.691 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.602 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.96 HG23 HG11 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.572 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.87 HG21 HD11 ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.998 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.857 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.992 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.998 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 28' ' ' ASN . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.6 m-80 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.428 ' O ' HD13 ' A' ' 56' ' ' LEU . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.94 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.94 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.992 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.545 HG21 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.073 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.649 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.987 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.073 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.534 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 49' ' ' ASN . 0.9 OUTLIER -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.725 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.604 ' O ' HD12 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.987 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.482 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.629 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.756 HG21 HD11 ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.616 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.994 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 HG22 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.994 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 32' ' ' ILE . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.763 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' NE2' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.568 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.768 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.779 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.661 ' NE2' ' HA3' ' A' ' 37' ' ' GLY . 9.7 mm100 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' O ' HD12 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.865 HE21 ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.954 HG23 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 81' ' ' LEU . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 10' ' ' THR . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.719 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.684 ' HB2' HG21 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.931 ' HA ' HD13 ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.075 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' H ' ' A' ' 27' ' ' GLU . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 16.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.603 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.444 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.075 HG23 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.435 ' HB3' HG21 ' A' ' 66' ' ' ILE . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB3' HG21 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 22' ' ' ILE . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 16' ' ' HIS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.016 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.016 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.679 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.719 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.915 HE21 ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.723 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.667 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.546 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.41 ' HB2' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.667 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 79' ' ' GLY . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.741 ' HB2' HG21 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HZ1' HD12 ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.933 ' HA ' HD13 ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.419 HG21 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.657 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.644 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.741 HG21 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.58 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.995 HG23 HG11 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.74 ' HB2' HG21 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.483 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.037 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.958 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.037 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.1 m-80 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 29' ' ' VAL . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.573 ' HD3' HD21 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 53' ' ' ASN . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.523 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 9.3 mm100 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.74 HG21 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.958 HG23 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.588 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.514 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 22' ' ' ILE . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.584 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.01 ' HA ' HD13 ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.647 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.01 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.552 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.635 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.555 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.4 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HD2' HG23 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 45' ' ' GLN . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.659 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.647 HG23 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.584 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 22' ' ' ILE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 14' ' ' PRO . 24.0 p80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.982 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.982 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 29' ' ' VAL . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 15.3 mm100 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 45' ' ' GLN . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.8 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.649 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.813 HG23 HG11 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.694 ' HB2' HG13 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 22' ' ' ILE . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 1.032 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.772 HD11 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.032 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.747 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.642 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.008 HG23 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.727 ' HB3' HG21 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HD11 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.597 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 17.8 p80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.809 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.937 HD11 HG21 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 29' ' ' VAL . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.72 HG21 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.707 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' HD12 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.974 HG23 HG11 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG22 HD11 ' A' ' 20' ' ' LEU . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 1.4 pm0 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.86 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.1 t-20 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 2.7 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 56' ' ' LEU . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 45' ' ' GLN . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 8' ' ' GLU . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.86 HG23 HG11 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HB2' HG13 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.575 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.98 137.23 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.778 0.323 . . . . 0.0 110.655 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 93.2 mtp -107.72 144.88 34.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 25.6 m -106.51 139.75 40.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.234 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.54 151.88 50.52 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 p -84.88 108.8 17.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 22' ' ' ILE . 13.6 mm -109.25 111.77 59.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.363 0.601 . . . . 0.0 110.943 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 89.1 Cg_exo -51.41 133.24 42.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.28 2.653 . . . . 0.0 113.059 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' HE2' ' A' ' 55' ' ' LYS . 91.5 m -58.07 -32.26 67.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.806 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -75.36 -19.37 59.63 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.314 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HA ' HD21 ' A' ' 20' ' ' LEU . 31.9 mtmt -94.27 7.63 44.67 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.644 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.085 ' HA ' HD13 ' A' ' 22' ' ' ILE . 13.1 p -75.18 13.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.305 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -117.0 -18.99 5.36 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.909 -1.138 . . . . 0.0 113.128 177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -90.5 -48.05 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.424 0.612 . . . . 0.0 110.587 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -91.1 -28.61 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.595 0.712 . . . . 0.0 110.228 -177.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.085 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.5 mp -101.26 -20.34 5.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.011 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 69.23 -124.53 16.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.147 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.46 -64.99 1.03 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.74 50.08 0.9 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.216 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.31 52.6 5.54 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.888 -0.673 . . . . 0.0 111.706 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -86.11 -56.96 3.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.919 0.39 . . . . 0.0 111.154 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 27.6 t-20 -68.43 -31.82 71.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 32' ' ' ILE . 30.2 m -63.72 -30.96 51.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 19.8 pttm -83.18 -18.24 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.411 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -71.98 -37.36 69.89 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 171.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 29' ' ' VAL . 49.9 mt -55.44 -46.61 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.462 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.9 t30 -52.06 -47.93 64.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.211 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 79.1 mt-30 -63.41 -35.34 80.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.051 0.453 . . . . 0.0 110.784 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.0 mm100 -72.73 -21.06 61.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.215 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 69' ' ' ALA . 38.5 p -122.49 -78.99 0.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -171.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.08 -26.34 0.71 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.793 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.22 146.76 25.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.184 0.516 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.529 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 23.9 t80 -87.17 107.41 18.46 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.177 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG12 ' CE1' ' A' ' 57' ' ' PHE . 17.1 t -84.81 95.73 4.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 6.3 pt-20 -115.07 149.31 37.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.582 -173.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 18.2 mt -75.68 127.81 37.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.82 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.43 ' HB2' HG13 ' A' ' 58' ' ' ILE . 15.5 t -91.44 173.91 7.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.465 0.65 . . . . 0.0 111.656 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -123.03 11.52 9.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.674 178.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.5 mt-30 -79.73 144.5 33.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.655 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.9 mt -80.22 130.37 66.14 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.051 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 56' ' ' LEU . 37.6 Cg_endo -66.01 164.88 25.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.499 2.132 . . . . 0.0 111.205 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.04 -31.57 44.97 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.23 1.953 . . . . 0.0 112.665 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -82.05 -15.72 52.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.331 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.7 26.23 68.32 Favored Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.629 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.14 132.55 21.02 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.537 0.208 . . . . 0.0 110.447 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 2.03 5.53 Favored 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.102 2.535 . . . . 0.0 114.393 -174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -92.83 0.14 57.36 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.767 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.65 96.18 4.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.518 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HE2' HG23 ' A' ' 15' ' ' THR . 68.1 mttm -80.59 123.05 27.8 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.661 176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 45' ' ' GLN . 34.2 mt -72.46 138.53 47.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -117.04 136.07 53.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.342 -179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' HB ' ' HG2' ' A' ' 41' ' ' GLU . 7.2 mt -98.65 112.9 31.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.582 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.494 ' HB ' HG23 ' A' ' 66' ' ' ILE . 48.3 mt -99.51 90.24 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 169.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 7.9 ptm180 -98.05 118.51 34.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.455 0.645 . . . . 0.0 111.778 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.66 -152.69 17.07 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.436 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.7 m -88.3 148.35 42.34 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -42.3 -48.25 6.74 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.292 2.662 . . . . 0.0 113.589 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -55.69 -39.25 70.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 111.421 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -78.49 -42.09 30.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.094 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.7 mt -60.8 -53.1 53.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.36 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.8 t70 -62.85 -36.25 82.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.005 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.487 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.1 t-160 -70.79 -39.18 73.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.971 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -65.4 -41.1 94.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 109.937 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 50.8 tttm -49.93 -48.3 51.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.58 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -59.99 -39.46 85.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.649 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 17.7 mt -70.01 -32.94 71.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.822 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.776 HG23 HG11 ' A' ' 21' ' ' VAL . 46.4 mt -75.45 -39.69 41.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.012 0.434 . . . . 0.0 109.938 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -67.98 -16.71 64.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.333 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -81.49 -33.69 31.75 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.659 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 39.7 mmtm -68.67 -49.95 54.99 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.329 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.538 HG13 ' H ' ' A' ' 79' ' ' GLY . 41.4 pt -87.1 -14.93 9.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 56.01 38.59 30.1 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.582 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.23 162.93 29.39 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.542 -177.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.28 132.57 16.6 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.719 2.279 . . . . 0.0 112.89 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 81' ' ' LEU . 28.9 mt -101.83 138.82 38.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.544 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.9 m -95.82 125.98 46.76 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.568 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.28 112.8 2.88 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.335 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.567 HG21 HD22 ' A' ' 56' ' ' LEU . 7.0 m -115.64 167.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.949 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.233 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -64.01 131.79 48.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.667 ' HB2' HG21 ' A' ' 66' ' ' ILE . 26.3 mmt -111.99 144.53 41.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.329 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 21.6 m -111.92 145.13 40.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.181 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.84 151.44 52.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.612 0.244 . . . . 0.0 110.474 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 37.4 p -82.54 110.95 18.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.237 -176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.727 HG21 HD11 ' A' ' 22' ' ' ILE . 32.6 mm -108.64 104.81 55.53 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 121.59 0.71 . . . . 0.0 111.159 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 12.7 Cg_exo -47.47 141.3 14.78 Favored 'Trans proline' 0 N--CA 1.476 0.481 0 C-N-CA 124.533 3.488 . . . . 0.0 115.197 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' HE2' ' A' ' 55' ' ' LYS . 26.5 m -77.07 70.02 3.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.67 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 p80 178.31 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.457 175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 21' ' ' VAL . 35.7 mtmt -87.89 0.98 55.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.418 172.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.098 ' HA ' HD13 ' A' ' 22' ' ' ILE . 7.7 p -77.84 20.98 0.32 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.75 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.29 -22.93 1.63 Allowed Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.007 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -89.81 -43.39 10.68 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.275 -0.544 . . . . 0.0 111.364 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.039 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -88.96 -32.32 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.62 0.724 . . . . 0.0 109.75 176.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.098 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.5 mp -94.11 -34.63 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.371 -171.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 -163.99 36.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.269 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -71.36 101.56 2.41 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.84 -64.37 3.9 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.934 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -178.15 57.11 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.8 tp10 -90.28 -57.84 2.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.347 -0.427 . . . . 0.0 111.339 -175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.452 ' O ' HG13 ' A' ' 32' ' ' ILE . 83.3 m-20 -69.52 -18.56 63.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -169.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.773 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.8 m -67.76 -26.86 36.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.776 0.322 . . . . 0.0 111.504 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 46.5 pttt -77.65 -27.43 50.97 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -68.7 -40.07 80.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.7 mt -54.23 -45.74 67.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 25.5 t-20 -56.53 -50.11 72.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.481 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 29.3 mm-40 -61.91 -34.21 75.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.967 -178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.2 mm-40 -76.02 -21.45 56.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.246 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.0 p -117.8 -75.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.75 -21.3 2.35 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.41 150.61 21.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.954 0.406 . . . . 0.0 110.776 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 94.7 m-85 -90.55 118.97 30.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.498 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 t -99.4 92.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.185 0.517 . . . . 0.0 109.956 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.78 176.52 5.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.143 179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.515 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 mt -99.08 134.93 36.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.924 0.392 . . . . 0.0 110.249 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 19.1 t -90.5 169.04 11.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.357 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -129.47 26.33 5.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.701 176.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -90.2 177.3 6.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.421 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.4 mt -124.44 131.03 24.12 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-O 120.797 0.332 . . . . 0.0 110.256 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.94 170.93 8.08 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 123.076 2.517 . . . . 0.0 111.544 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.84 -0.91 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.361 2.707 . . . . 0.0 113.836 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -108.05 -13.02 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.86 0.362 . . . . 0.0 110.986 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.98 71.13 Favored Glycine 0 C--N 1.333 0.365 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -170.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.32 124.67 62.36 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.761 -171.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.29 -5.86 14.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.0 2.467 . . . . 0.0 113.456 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -82.42 -17.26 46.05 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.306 0.574 . . . . 0.0 110.2 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -103.96 90.54 3.64 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.608 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.415 ' HE2' HG23 ' A' ' 15' ' ' THR . 53.1 mttm -79.27 109.41 13.59 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.491 0.662 . . . . 0.0 109.387 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 84' ' ' VAL . 63.0 mt -69.27 143.96 53.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.57 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 1.8 m-85 -118.01 133.25 56.1 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.497 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.491 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 40.5 mt -91.63 114.6 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.841 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' HB ' HG23 ' A' ' 66' ' ' ILE . 70.9 mt -102.15 95.03 3.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 4.9 ptm180 -96.85 127.98 43.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.406 0.622 . . . . 0.0 111.511 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.32 -154.79 25.33 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 66' ' ' ILE . 93.5 p -85.92 157.67 57.03 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.46 -41.64 36.04 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.246 1.964 . . . . 0.0 112.143 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.79 -30.94 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.308 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -78.82 -43.08 26.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.432 . . . . 0.0 110.376 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.667 HG21 ' HB2' ' A' ' 9' ' ' MET . 63.5 mt -65.24 -52.84 47.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.35 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.36 -35.04 76.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.471 . . . . 0.0 110.218 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.578 ' O ' HD12 ' A' ' 72' ' ' LEU . 10.5 t-160 -58.87 -52.81 64.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.54 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.94 -43.1 95.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.641 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -50.32 -43.24 53.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.841 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.24 -53.34 56.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.353 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.676 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 5.0 mp -55.21 -38.64 68.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.292 178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.039 HG23 HG11 ' A' ' 21' ' ' VAL . 52.8 mt -68.68 -42.95 83.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.722 0.296 . . . . 0.0 110.805 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 51.1 mt-10 -65.98 -20.01 66.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -83.84 -34.72 24.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.008 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.3 mmtm -65.39 -38.27 89.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.915 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 32.0 pt -100.14 -13.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.95 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 56.12 48.29 17.83 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.78 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.08 155.65 26.73 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.784 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 75.5 Cg_endo -78.58 138.48 15.35 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.648 2.232 . . . . 0.0 112.459 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -108.11 138.87 43.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.071 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 60.0 m -89.4 132.69 36.55 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.309 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.6 Cg_exo -70.52 104.9 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.949 2.433 . . . . 0.0 112.145 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 56' ' ' LEU . 45.5 t -85.61 133.75 28.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.793 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.616 -177.566 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.242 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 60' ' ' ARG . 28.3 mt-10 -73.07 141.68 47.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.667 -0.267 . . . . 0.0 110.377 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.579 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.1 mtt -114.79 121.34 42.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.48 139.86 35.56 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 70' ' ' LYS . 97.6 m-85 -128.2 152.29 48.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -80.99 113.93 19.53 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.628 -176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.858 HG21 HD11 ' A' ' 22' ' ' ILE . 10.6 mm -114.49 108.61 49.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.459 0.647 . . . . 0.0 111.107 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 70.1 Cg_exo -51.17 131.01 34.13 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 123.312 2.674 . . . . 0.0 112.74 174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.436 ' OG1' ' HG3' ' A' ' 55' ' ' LYS . 12.5 m -59.46 -29.49 67.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.851 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -75.87 -21.16 57.48 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 121.112 -0.235 . . . . 0.0 111.363 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 14' ' ' PRO . 39.7 mtmt -92.88 11.81 25.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.03 ' HA ' HD13 ' A' ' 22' ' ' ILE . 18.4 p -75.33 26.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.208 0.528 . . . . 0.0 111.802 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -126.05 -40.13 0.39 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.765 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD11 HG22 ' A' ' 77' ' ' ILE . 3.7 pp -73.5 -33.65 64.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.529 0.164 . . . . 0.0 111.046 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.833 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.62 -30.86 2.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.589 176.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.03 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -96.87 -65.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.378 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.17 -161.62 23.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.289 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.21 99.16 3.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.544 0.212 . . . . 0.0 110.932 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.31 40.39 96.51 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.223 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.62 12.18 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.358 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -85.03 -34.7 22.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.29 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 13.9 t-20 -86.18 -36.3 19.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HA ' HD12 ' A' ' 32' ' ' ILE . 29.3 m -62.37 -27.76 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.074 -175.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -76.3 -22.34 55.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.122 0.487 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -85.61 -27.25 25.57 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' A' ' 29' ' ' VAL . 32.2 mt -61.02 -45.41 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -55.82 -52.59 63.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.128 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 19.5 pt20 -60.95 -31.96 71.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.956 0.407 . . . . 0.0 111.303 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 9.9 mm-40 -78.07 -27.96 48.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.505 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.71 HG21 ' HA ' ' A' ' 69' ' ' ALA . 47.1 p -108.35 -59.11 1.91 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.45 -16.64 9.75 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.87 155.06 19.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.749 0.309 . . . . 0.0 111.27 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.751 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 69.0 m-85 -96.43 110.87 23.15 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.582 -177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 14.9 t -94.49 95.21 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -99.84 157.42 16.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.827 -171.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.9 mp -98.54 108.42 22.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.679 ' OG ' HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.17 179.61 5.88 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.443 0.639 . . . . 0.0 112.614 -166.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.589 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -130.54 14.2 5.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.176 -176.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -86.32 132.03 34.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.018 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.26 137.55 34.79 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 34.3 Cg_endo -65.36 151.12 86.14 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.202 1.935 . . . . 0.0 110.341 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.5 -13.99 15.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.439 2.759 . . . . 0.0 113.245 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -89.79 -11.94 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.094 0.473 . . . . 0.0 111.375 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.06 45.13 58.15 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.43 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.553 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 7.6 t0 -108.86 116.36 55.89 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 6.3 Cg_exo -76.28 -5.84 16.6 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 123.496 2.798 . . . . 0.0 113.705 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 21.9 t-20 -93.54 2.15 56.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 109.578 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -123.63 86.97 2.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.148 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG3' ' OG1' ' A' ' 15' ' ' THR . 56.6 mtpt -79.5 124.03 28.11 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.544 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 84' ' ' VAL . 4.6 mm? -69.49 140.89 54.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.385 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.616 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -123.19 117.9 26.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.932 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.679 HG13 ' OG ' ' A' ' 43' ' ' SER . 74.3 mt -86.17 132.93 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.56 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 66' ' ' ILE . 44.0 mt -116.38 100.49 10.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 27.0 ptt180 -98.34 150.62 21.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.88 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.31 -161.24 24.92 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 p -76.34 137.8 67.96 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.92 -28.88 41.24 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.784 2.989 . . . . 0.0 114.035 -173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -76.63 -30.41 56.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 110.412 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 13.7 mt-30 -78.41 -43.0 28.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 175.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 59' ' ' ILE . 59.2 mt -51.82 -58.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.369 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 23.0 t70 -61.46 -37.05 82.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.062 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 t-160 -63.6 -45.63 89.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.84 -41.63 98.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.208 0.528 . . . . 0.0 110.051 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 11' ' ' PHE . 18.5 tttm -54.17 -38.17 65.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.028 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 78.2 mt-30 -61.6 -51.06 70.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.457 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.4 mp -53.4 -35.59 60.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.753 0.311 . . . . 0.0 111.135 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.833 HG23 HG11 ' A' ' 21' ' ' VAL . 70.1 mt -73.18 -42.81 58.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.749 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 55.3 mt-10 -63.18 -23.73 67.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.111 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -83.74 -31.94 25.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.699 0.285 . . . . 0.0 110.297 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 45.5 mmtm -61.85 -46.37 89.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.337 0.589 . . . . 0.0 110.348 175.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.552 HG22 HD11 ' A' ' 20' ' ' LEU . 30.8 pt -92.53 -11.45 9.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.019 -176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 56.31 53.81 8.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.882 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.49 143.66 8.1 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.336 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 44.1 Cg_endo -68.75 134.88 31.36 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.611 2.207 . . . . 0.0 112.108 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.92 147.08 24.82 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 111.611 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 69.9 m -98.43 130.77 27.42 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.537 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.49 115.58 3.96 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.677 2.251 . . . . 0.0 111.532 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' HB ' HD11 ' A' ' 56' ' ' LEU . 21.7 t -108.18 143.2 19.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.475 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 176.535 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -67.96 125.05 25.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.173 0.511 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.462 ' CB ' HG21 ' A' ' 66' ' ' ILE . 26.5 tpp -99.69 103.78 15.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -174.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.77 122.76 40.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.93 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -110.17 176.23 5.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.324 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -103.3 115.78 31.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.459 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 22' ' ' ILE . 14.3 mm -114.01 113.67 46.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 121.391 0.615 . . . . 0.0 111.162 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 88.9 Cg_exo -53.81 133.73 55.72 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 123.533 2.822 . . . . 0.0 112.795 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 m -67.77 -17.67 64.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.099 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 39.1 p-80 -83.23 -16.58 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.557 176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.2 mtmt -101.09 9.58 41.91 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.066 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.052 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.8 p -73.64 7.65 2.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -176.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 23' ' ' GLY . . . -112.26 -40.6 1.13 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.331 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 77' ' ' ILE . 1.5 pp -72.34 -34.69 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 122.737 -0.272 . . . . 0.0 111.593 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.984 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.71 -26.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.453 177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.052 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -104.71 -63.39 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.269 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HA2' ' A' ' 19' ' ' GLY . . . 131.56 -137.93 9.8 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.57 175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -113.55 -26.13 8.43 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.75 -0.23 4.01 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.41 45.14 1.17 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -78.22 -41.24 34.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' ILE . 39.4 t-20 -71.53 -48.15 50.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.917 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.776 HG13 ' HA ' ' A' ' 22' ' ' ILE . 28.4 m -63.24 -27.68 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -175.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 6.5 ptpp? -77.17 -30.19 54.78 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.681 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.81 -38.86 67.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.745 HG23 HD12 ' A' ' 72' ' ' LEU . 59.6 mt -51.5 -49.36 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.569 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -53.25 -50.21 65.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 70.5 mt-30 -63.99 -30.94 71.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.148 0.499 . . . . 0.0 111.015 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.3 mm-40 -80.29 -18.49 49.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.745 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 69' ' ' ALA . 44.2 p -120.28 -55.42 2.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.49 -24.6 6.13 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.91 144.69 25.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 97.5 m-85 -80.83 115.49 20.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.968 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.64 HG12 ' HE2' ' A' ' 57' ' ' PHE . 12.7 t -97.89 88.69 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -103.22 157.43 17.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.958 -172.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' CE1' ' A' ' 57' ' ' PHE . 14.9 mt -87.59 116.04 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -73.56 164.65 26.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.397 0.617 . . . . 0.0 111.248 -170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 2.5 mpt_? -104.86 2.7 30.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.272 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -92.33 140.67 29.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.284 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.94 155.56 44.97 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.28 159.51 39.23 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.524 2.149 . . . . 0.0 111.296 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.02 -14.27 32.25 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.856 2.371 . . . . 0.0 111.682 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -91.21 -16.3 27.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.716 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.7 23.86 72.48 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.577 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 t70 -71.75 119.76 76.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 23.1 Cg_exo -64.85 -23.94 61.73 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 123.064 2.509 . . . . 0.0 113.571 -173.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -89.37 -11.14 44.12 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.132 -174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.7 109.68 21.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 0.0 110.564 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -98.07 129.8 44.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.605 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.89 139.26 52.97 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.64 ' HE2' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -125.57 119.18 27.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.245 -179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mt -89.26 116.6 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.371 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 73' ' ' ILE . 49.9 mt -100.92 90.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 167.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.487 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 7.8 ptm180 -102.05 123.59 46.2 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.079 -170.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.88 -116.23 0.6 Allowed Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.326 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.3 p -128.94 149.23 71.88 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.2 -43.72 10.04 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.927 2.418 . . . . 0.0 113.214 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.436 ' NE2' ' H ' ' A' ' 64' ' ' GLN . 1.8 mp0 -67.46 -39.63 85.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.61 -177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -79.55 -40.6 29.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 9' ' ' MET . 47.8 mt -56.47 -54.76 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.503 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.89 -34.54 77.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.868 0.366 . . . . 0.0 111.132 -176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.2 t-160 -67.15 -39.93 86.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.072 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -69.12 -45.42 70.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.498 . . . . 0.0 110.108 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HE2' ' OE2' ' A' ' 74' ' ' GLU . 4.7 tmtt? -57.5 -36.54 71.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.677 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -42.34 98.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.125 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.745 HD12 HG23 ' A' ' 32' ' ' ILE . 34.6 mt -61.73 -40.79 96.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.984 HG23 HG11 ' A' ' 21' ' ' VAL . 62.2 mt -64.05 -46.46 93.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.655 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 91.8 mt-10 -66.51 -15.05 63.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.159 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -87.4 -31.88 19.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 21' ' ' VAL . 71.6 mmtt -71.8 -51.75 21.02 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 20' ' ' LEU . 30.2 pt -82.4 -18.92 10.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.668 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.8 mt-10 61.13 41.46 13.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.973 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.94 144.91 11.42 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.818 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.38 139.63 38.52 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.538 2.159 . . . . 0.0 112.718 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.8 mt -101.31 163.35 12.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.314 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 93.5 m -120.9 133.8 24.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 19.3 Cg_exo -66.55 114.15 2.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.969 2.446 . . . . 0.0 111.28 174.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -89.15 -57.83 3.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.207 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.088 -178.082 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.89 114.83 3.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.804 0.335 . . . . 0.0 111.039 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.424 ' HB2' HG21 ' A' ' 66' ' ' ILE . 86.7 mtp -96.42 126.87 41.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 24.6 m -97.56 142.25 29.62 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.508 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.7 m-85 -130.07 158.47 39.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.815 0.34 . . . . 0.0 110.182 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -85.19 106.49 16.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 22' ' ' ILE . 13.1 mm -108.92 108.4 60.66 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.226 0.536 . . . . 0.0 110.705 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 77.3 Cg_exo -51.17 131.33 35.2 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.916 2.411 . . . . 0.0 112.524 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.576 HG23 ' HE2' ' A' ' 55' ' ' LYS . 51.1 m -58.06 -28.08 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.761 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -78.57 -16.48 57.37 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.36 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HD2' HD11 ' A' ' 20' ' ' LEU . 30.1 mtmt -99.35 14.14 30.72 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.695 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.076 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.6 p -74.7 12.12 0.89 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.333 0.587 . . . . 0.0 111.14 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.56 -29.32 2.72 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.864 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD11 ' HD2' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -81.8 -50.61 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.349 0.574 . . . . 0.0 110.824 177.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.967 HG11 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -89.47 -27.03 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.592 -177.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.076 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.0 mp -100.81 -53.16 7.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.072 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.27 25.6 28.15 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.962 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.0 ttt180 66.8 109.73 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.174 0.512 . . . . 0.0 110.23 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 -60.48 3.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.47 -175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.5 53.84 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.029 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 5.4 mm-40 -86.17 -41.56 14.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.442 0.163 . . . . 0.0 111.198 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 11.0 t-20 -72.35 -36.89 68.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.075 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' HD12 ' A' ' 32' ' ' ILE . 34.5 m -68.26 -28.92 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.769 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 19.9 pttm -74.86 -28.69 60.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.594 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.17 -38.8 75.5 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 72' ' ' LEU . 60.3 mt -52.82 -47.06 52.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.399 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 24.7 t-20 -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.395 177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 82.5 mt-30 -63.22 -34.87 78.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.666 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 10.5 mm100 -78.87 -20.11 50.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.35 -178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.2 p -118.74 -72.02 0.71 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -171.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.6 -21.45 2.89 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 149.46 22.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.789 0.328 . . . . 0.0 110.667 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 86.3 m-85 -87.53 111.49 21.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.84 92.71 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.72 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.4 pt-20 -116.24 -179.73 3.75 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.653 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.9 mt -101.82 139.42 23.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 16.1 t -93.1 169.03 10.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.473 0.654 . . . . 0.0 111.389 -173.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.68 1.0 14.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.132 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -78.38 153.77 31.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.735 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.5 mm? -94.82 126.77 45.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.973 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 38.6 Cg_exo -59.71 158.11 29.8 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.274 2.65 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.05 -3.86 9.21 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.177 2.585 . . . . 0.0 112.232 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -94.23 -11.69 29.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.096 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 54.7 35.87 58.35 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.144 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.45 129.32 24.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.605 0.241 . . . . 0.0 110.466 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.22 -5.33 16.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.037 2.491 . . . . 0.0 113.903 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -84.31 5.59 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.0 110.014 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -124.21 113.15 17.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.338 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HE2' HG23 ' A' ' 15' ' ' THR . 67.5 mttm -95.64 117.67 30.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.045 0.45 . . . . 0.0 109.929 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 56.1 mt -69.61 131.6 44.89 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.081 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -111.49 135.82 51.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.119 0.485 . . . . 0.0 110.827 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 46.8 mt -95.45 129.2 45.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.435 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 66' ' ' ILE . 55.6 mt -118.17 96.88 4.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 166.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 15.2 ptt180 -99.68 133.1 44.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 111.795 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.02 -157.89 28.4 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.626 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.1 m -82.78 146.52 52.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 117.066 0.433 . . . . 0.0 109.862 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.68 -50.25 3.96 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.901 3.067 . . . . 0.0 114.256 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -63.3 -35.51 80.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.648 0.261 . . . . 0.0 111.375 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -77.84 -35.43 51.11 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 59' ' ' ILE . 43.5 mt -62.2 -56.4 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.83 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 20.1 t70 -65.58 -33.18 75.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 23.4 t-160 -62.4 -38.8 91.05 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.95 -41.8 77.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.238 0.542 . . . . 0.0 109.93 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 20.3 tttm -55.9 -41.01 73.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.797 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 85.6 mm-40 -59.95 -42.11 93.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.635 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.696 HD12 HG23 ' A' ' 32' ' ' ILE . 40.2 mt -63.58 -38.55 91.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.967 HG23 HG11 ' A' ' 21' ' ' VAL . 55.2 mt -68.4 -42.99 84.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.478 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 57.7 mt-10 -67.15 -15.6 63.81 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.788 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -86.64 -28.71 23.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.211 0.529 . . . . 0.0 109.961 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 34.4 mmtm -72.19 -48.75 40.86 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.306 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 73' ' ' ILE . 29.7 pt -90.45 -19.24 7.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.522 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 21.7 mt-10 56.51 60.53 3.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.127 -176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.8 149.73 11.74 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.623 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 61.1 Cg_endo -73.25 128.57 13.04 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.461 2.107 . . . . 0.0 112.981 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -93.79 157.46 16.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.981 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 79.6 m -113.25 128.37 25.74 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.501 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.6 Cg_exo -66.31 125.46 14.02 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.951 2.434 . . . . 0.0 112.052 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 10' ' ' THR . 57.6 t -114.75 140.69 34.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.711 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.066 177.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.648 -0.181 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.627 ' HB3' HG23 ' A' ' 58' ' ' ILE . 2.2 mp0 -92.91 117.46 30.07 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 122.809 -0.23 . . . . 0.0 110.936 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.457 ' HB2' HG21 ' A' ' 66' ' ' ILE . 67.2 mtt -98.66 129.83 45.16 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.569 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 1.1 m -105.79 139.18 40.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.71 -174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 94.5 m-85 -130.04 147.78 51.82 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.4 p -78.84 115.15 18.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.46 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.655 HG21 HD11 ' A' ' 22' ' ' ILE . 10.5 mm -113.0 115.37 48.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.393 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 99.8 Cg_exo -54.62 125.92 20.64 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.126 2.55 . . . . 0.0 112.216 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 m -55.81 -33.01 64.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.372 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.455 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 13.6 p80 -69.94 -23.22 63.16 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.828 0.346 . . . . 0.0 111.43 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.7 mtmt -92.03 14.0 17.14 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.947 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -75.14 19.8 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.932 0.396 . . . . 0.0 111.953 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.79 -41.65 0.37 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.961 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 21' ' ' VAL . 3.5 pp -75.93 -17.5 59.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.727 -0.278 . . . . 0.0 111.582 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.973 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.14 -31.19 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.204 172.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.3 mp -98.42 -72.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.582 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.92 71.41 1.17 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.346 -0.931 . . . . 0.0 111.928 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 57.72 -93.03 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.033 0.533 . . . . 0.0 112.158 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.6 2.96 70.94 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.8 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 55.0 0.86 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.305 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 34.1 tt0 -78.14 -31.98 50.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.076 0.465 . . . . 0.0 110.327 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 45.1 t-20 -81.64 -39.45 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.039 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.624 ' HA ' HD12 ' A' ' 32' ' ' ILE . 25.3 m -64.86 -29.17 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 21.6 ptmt -73.85 -26.58 60.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.111 0.481 . . . . 0.0 109.722 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -75.5 -33.48 60.77 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.9 mt -56.45 -42.67 75.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.6 t-20 -60.51 -47.25 86.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.65 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 19.5 pt20 -67.3 -24.12 65.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 110.728 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm100 -83.28 -25.02 31.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.371 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.7 p -115.27 -78.88 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -170.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.49 -23.76 1.52 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -172.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -88.52 152.31 21.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.929 0.395 . . . . 0.0 110.469 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 90.8 m-85 -94.81 116.41 28.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 21.9 t -94.85 94.76 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 25.1 mt-10 -97.86 146.3 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.092 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.526 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 10.4 mt -72.51 113.2 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 8.2 t -78.24 162.78 26.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.118 0.485 . . . . 0.0 111.423 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -115.8 14.01 16.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.204 175.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -84.69 114.68 22.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.002 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.04 138.41 46.07 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 18.5 Cg_endo -58.9 155.24 39.47 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.835 2.357 . . . . 0.0 111.63 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 47' ' ' PRO . 25.4 Cg_exo -63.82 -2.24 4.25 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.02 2.48 . . . . 0.0 112.051 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -95.12 -16.02 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.73 26.61 73.75 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.396 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 53' ' ' ASN . 6.7 t70 -101.17 126.2 35.55 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.649 0.261 . . . . 0.0 111.324 -173.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.74 2.4 7.88 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.705 2.27 . . . . 0.0 113.846 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 51' ' ' ASP . 3.0 m-20 -88.67 -17.7 29.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.004 0.43 . . . . 0.0 111.133 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.4 76.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.207 0.527 . . . . 0.0 109.947 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -79.54 122.46 26.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.909 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.6 mm? -69.61 149.46 48.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.443 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -127.87 141.16 51.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.197 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 8' ' ' GLU . 52.6 mt -95.35 133.42 36.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.923 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.428 ' HB ' HG23 ' A' ' 66' ' ' ILE . 50.9 mt -123.39 100.36 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 165.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.618 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 14.6 ptm180 -101.04 134.25 44.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.5 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.65 -145.25 12.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.255 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.0 p -101.41 149.66 36.54 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -39.05 -47.41 2.92 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.728 2.952 . . . . 0.0 113.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.37 -38.75 88.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 111.243 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 21.1 mt-30 -78.46 -42.84 28.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.303 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 9' ' ' MET . 52.2 mt -62.65 -53.37 47.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.283 -178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -64.02 -30.96 72.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.084 0.469 . . . . 0.0 110.597 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.511 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.1 t-160 -66.51 -43.9 84.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.35 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -68.76 -42.67 77.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.201 0.524 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 11' ' ' PHE . 19.9 tttm -54.67 -44.64 73.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.812 175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -66.56 -31.98 73.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.031 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 20.6 mt -66.03 -37.04 84.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.973 HG23 HG11 ' A' ' 21' ' ' VAL . 70.6 mt -68.82 -42.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.229 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 48.3 mt-10 -60.88 -24.71 66.16 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.457 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -81.89 -34.12 30.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.515 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -65.01 -58.85 5.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.285 0.564 . . . . 0.0 110.148 177.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 20' ' ' LEU . 27.4 pt -81.28 -16.52 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.74 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 19.3 mt-10 59.19 56.39 3.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.092 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.67 145.98 9.13 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 56.0 Cg_endo -71.41 147.9 53.47 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.56 2.173 . . . . 0.0 112.562 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.9 mt -114.32 149.65 35.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.725 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 64.7 m -99.54 133.05 22.17 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.688 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.64 110.22 2.48 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.633 2.222 . . . . 0.0 111.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' ' HB ' ' A' ' 10' ' ' THR . 21.6 t -107.18 127.42 62.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.593 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.807 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.335 177.277 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.699 -0.16 . . . . 0.0 112.699 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.6 pt-20 -93.68 88.42 5.83 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.957 0.408 . . . . 0.0 111.27 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.681 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.78 133.13 43.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.9 m -110.5 130.07 55.64 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.77 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.767 ' HB3' HD12 ' A' ' 81' ' ' LEU . 85.9 m-85 -130.56 150.78 51.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.994 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.402 ' HB3' HG21 ' A' ' 84' ' ' VAL . 17.0 p -93.3 113.33 25.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -175.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 73' ' ' ILE . 18.7 mt -111.43 121.16 40.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.349 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 21.2 Cg_exo -44.13 134.05 8.66 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.783 2.988 . . . . 0.0 113.668 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 85.9 m -62.18 -21.34 65.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.575 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -81.88 -23.18 36.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.736 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 29.2 mtmt -91.4 3.56 54.62 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.551 0.215 . . . . 0.0 111.053 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.3 p -68.45 9.88 0.3 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.363 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -113.41 -27.8 3.49 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.581 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.828 HD11 HG22 ' A' ' 77' ' ' ILE . 3.0 pp -90.23 -32.85 16.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.173 0.486 . . . . 0.0 111.54 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.939 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.6 -15.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.485 0.66 . . . . 0.0 110.618 178.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.4 mp -107.85 -51.97 7.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.027 -171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.07 -141.34 16.2 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.178 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -105.66 -37.36 6.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.96 15.59 5.09 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.21 34.09 7.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.157 -0.545 . . . . 0.0 112.588 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.7 -36.75 62.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.877 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.637 ' O ' HG13 ' A' ' 32' ' ' ILE . 4.8 t-20 -69.97 -42.2 73.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.654 -173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.0 m -65.16 -36.58 78.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.946 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 19.0 ptpt -82.29 -18.29 42.85 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.207 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -72.02 -35.71 69.48 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 171.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.9 mt -55.01 -45.87 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.146 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.3 t-20 -52.09 -49.79 62.88 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.9 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 63.6 mt-30 -59.58 -34.96 73.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 110.446 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 27.5 mm-40 -77.34 -20.28 55.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.575 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 69' ' ' ALA . 37.3 p -123.95 -67.28 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -169.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.82 -32.02 1.95 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.8 146.16 29.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 120.856 0.36 . . . . 0.0 110.765 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -86.37 107.94 18.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.453 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 HG12 ' A' ' 59' ' ' ILE . 22.0 t -91.98 94.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.293 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.687 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 3.5 pt-20 -107.08 176.4 5.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.529 176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.478 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -101.91 121.74 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 47.5 t -74.34 155.62 37.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.475 0.655 . . . . 0.0 111.609 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 44' ' ' ARG . 7.4 mpt_? -107.37 5.08 27.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.7 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -90.46 169.28 11.18 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.33 -174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.71 141.75 24.32 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.903 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.47 168.85 20.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 123.071 2.514 . . . . 0.0 111.834 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.82 -14.88 39.11 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.063 2.509 . . . . 0.0 112.421 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -85.01 -19.38 32.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.2 0.524 . . . . 0.0 110.071 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.86 11.72 81.02 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.864 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.33 119.68 67.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.42 -6.78 19.71 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.983 2.456 . . . . 0.0 110.774 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -70.13 -11.75 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.018 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -119.42 113.37 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.416 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 70.3 mmtt -87.29 118.08 26.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.397 0.618 . . . . 0.0 110.442 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 9.0 mp -69.89 139.99 53.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.544 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 29' ' ' VAL . 3.6 m-85 -118.71 130.98 56.12 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.138 0.494 . . . . 0.0 111.057 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.687 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 45.8 mt -93.72 105.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.507 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG12 HG13 ' A' ' 40' ' ' VAL . 62.6 mt -100.61 89.1 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 8' ' ' GLU . 8.1 ptm180 -98.22 118.07 34.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.712 0.768 . . . . 0.0 111.479 -170.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.83 -141.62 5.26 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.586 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 66' ' ' ILE . 80.1 p -100.35 152.49 37.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -46.87 -45.29 20.91 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.762 2.308 . . . . 0.0 113.214 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -68.61 -29.39 67.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.273 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -78.91 -43.97 23.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.681 HG21 ' HB2' ' A' ' 9' ' ' MET . 61.4 mt -59.28 -56.91 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.515 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.39 -33.42 74.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.114 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.607 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.7 t-160 -67.08 -36.24 81.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -70.13 -44.87 68.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 109.86 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -55.15 -44.05 74.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.062 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -68.18 -30.45 69.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.051 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.651 HD12 HG23 ' A' ' 32' ' ' ILE . 37.4 mt -64.15 -45.77 87.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.939 HG23 HG11 ' A' ' 21' ' ' VAL . 72.3 mt -60.56 -45.75 96.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.545 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.02 -29.98 63.81 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.213 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -85.43 -30.11 23.81 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.885 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 68.4 mmtt -65.21 -52.97 51.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.388 0.613 . . . . 0.0 109.912 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.828 HG22 HD11 ' A' ' 20' ' ' LEU . 17.9 pt -83.21 -12.69 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.511 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 61.77 32.76 18.14 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.766 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.39 174.07 29.86 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.715 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.61 164.17 21.08 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.776 2.317 . . . . 0.0 113.621 -172.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 11' ' ' PHE . 1.8 mm? -121.28 98.2 5.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.268 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 50.1 t -65.61 129.09 94.27 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.678 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 23.8 Cg_exo -64.44 133.68 38.37 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.728 2.285 . . . . 0.0 111.522 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 10' ' ' THR . 46.1 t -122.26 137.45 55.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.414 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.16 128.08 36.84 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.815 0.34 . . . . 0.0 110.883 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.1 mmm -100.86 141.69 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.62 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 5.3 m -109.39 138.09 46.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.27 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.99 141.04 51.38 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 82' ' ' CYS . 8.0 p -84.44 108.43 17.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.02 0.438 . . . . 0.0 111.103 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.775 HG21 HD11 ' A' ' 22' ' ' ILE . 10.4 mm -106.67 114.72 61.57 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.433 0.635 . . . . 0.0 111.126 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 12.3 Cg_exo -45.71 137.49 12.1 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 124.103 3.202 . . . . 0.0 113.561 173.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 43.1 m -60.1 -32.13 70.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.146 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.455 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 19.2 p80 -72.18 -19.0 61.81 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.909 -0.317 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 40.2 mtmt -98.05 5.23 48.94 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.023 ' HA ' HD13 ' A' ' 22' ' ' ILE . 14.1 p -77.85 12.17 1.86 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 111.583 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -116.5 -34.16 1.34 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.181 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 HG22 ' A' ' 21' ' ' VAL . 1.3 pp -77.32 -35.7 54.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.948 0.374 . . . . 0.0 111.514 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.96 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.84 -27.96 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 120.965 0.412 . . . . 0.0 111.096 177.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.023 HD13 ' HA ' ' A' ' 18' ' ' CYS . 4.3 mp -107.57 -32.8 2.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.406 -170.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.73 21.19 72.41 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.112 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? 67.66 114.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.311 0.644 . . . . 0.0 110.14 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.28 -54.33 3.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.874 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.19 52.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.544 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 3.9 mm-40 -90.32 -48.81 6.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 0.0 111.175 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.4 m-20 -70.52 -27.74 64.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.642 -176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 22' ' ' ILE . 33.5 m -69.01 -28.02 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.386 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 18.4 pttm -76.94 -20.37 56.24 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -79.22 -34.21 43.05 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.861 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 29' ' ' VAL . 38.3 mt -56.21 -45.37 81.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -56.15 -50.62 70.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.709 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.4 pt20 -66.62 -20.93 66.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.189 0.519 . . . . 0.0 111.076 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -87.18 -23.38 24.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.743 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.547 HG21 ' HA ' ' A' ' 69' ' ' ALA . 62.1 p -115.62 -64.18 1.35 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -169.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.02 -24.15 3.83 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.59 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 149.24 22.54 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.909 0.385 . . . . 0.0 110.574 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -90.08 113.04 24.69 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.212 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.06 86.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.77 149.02 25.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.642 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' H ' HG12 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -81.24 121.51 34.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' HG13 ' A' ' 58' ' ' ILE . 22.9 t -80.67 158.09 25.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.493 0.663 . . . . 0.0 111.831 -170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' N ' ' HD3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -108.62 -0.62 20.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.121 178.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.85 138.01 31.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.772 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -86.82 150.53 50.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.065 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 1.6 Cg_endo -78.47 153.37 27.11 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.634 2.223 . . . . 0.0 111.849 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.3 -45.79 12.14 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.159 2.573 . . . . 0.0 113.446 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -64.02 -21.23 66.42 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.22 36.11 56.29 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.783 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -105.59 123.82 38.22 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.689 0.281 . . . . 0.0 110.312 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -0.8 11.02 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.14 2.56 . . . . 0.0 113.846 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.67 -10.05 56.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.552 . . . . 0.0 110.15 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -105.88 124.47 49.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.304 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -107.28 113.23 26.49 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.683 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.17 143.84 52.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.691 ' CZ ' HG12 ' A' ' 22' ' ' ILE . 5.2 m-85 -126.35 132.63 51.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.017 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 43' ' ' SER . 12.6 mt -101.36 103.45 14.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.07 97.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -103.97 125.55 50.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.375 0.607 . . . . 0.0 111.269 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.88 -158.85 31.7 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.5 p -81.71 148.54 61.92 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 117.411 0.605 . . . . 0.0 109.748 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -43.14 -46.46 9.15 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.951 2.434 . . . . 0.0 113.497 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -60.76 -34.31 74.26 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -78.47 -42.0 31.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.801 0.334 . . . . 0.0 110.191 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.47 -48.71 87.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.12 -41.71 98.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.282 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.602 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.2 t-160 -59.21 -53.78 54.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.608 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -55.65 -42.55 75.19 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.543 0.527 . . . . 0.0 110.936 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.767 ' HG3' HD12 ' A' ' 81' ' ' LEU . 39.8 tttp -52.95 -39.3 62.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.459 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -71.37 -43.16 67.41 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.648 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.9 mp -54.32 -44.1 71.77 Favored 'General case' 0 CA--C 1.524 -0.053 0 CA-C-O 121.021 0.439 . . . . 0.0 110.207 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.96 HG23 HG11 ' A' ' 21' ' ' VAL . 57.5 mt -64.74 -44.45 96.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.904 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 88.4 mt-10 -69.34 -13.07 62.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.544 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -83.52 -34.71 25.23 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 172.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.0 mmtt -72.32 -46.09 57.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.825 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.572 HG13 ' H ' ' A' ' 79' ' ' GLY . 27.1 pt -88.11 -16.18 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 16.0 mt-10 54.62 37.58 28.37 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.777 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.572 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -151.71 172.4 31.12 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.416 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.98 143.38 22.98 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.594 2.196 . . . . 0.0 112.976 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 70' ' ' LYS . 62.5 mt -82.69 144.5 30.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.842 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.435 ' HB2' ' OG ' ' A' ' 12' ' ' SER . 57.8 m -98.3 111.84 60.69 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 16.4 Cg_exo -68.66 111.31 2.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.969 2.446 . . . . 0.0 112.024 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' THR . 11.9 t -124.06 158.72 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.441 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 C-N-CA 120.764 -0.732 . . . . 0.0 111.857 175.054 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -90.12 142.66 27.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.395 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.18 134.76 51.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.182 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -104.93 140.1 38.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.323 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.15 153.71 47.44 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.701 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.87 HG21 HD11 ' A' ' 22' ' ' ILE . 15.0 mm -104.59 116.33 61.25 Favored Pre-proline 0 C--O 1.221 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 111.167 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 83.1 Cg_exo -53.75 126.48 22.02 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 123.156 2.57 . . . . 0.0 113.228 177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.3 m -72.06 62.74 0.47 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.858 0.837 . . . . 0.0 111.071 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -168.64 -20.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.399 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 33.8 mtmt -96.17 11.43 34.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.164 170.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.998 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.1 p -78.83 28.25 0.21 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.374 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -129.73 -34.74 0.47 Allowed Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 173.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.857 HD12 HG22 ' A' ' 21' ' ' VAL . 3.2 pp -80.02 -22.81 42.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.601 0.238 . . . . 0.0 111.453 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.992 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -115.08 -36.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.135 0.493 . . . . 0.0 110.949 171.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.998 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.2 mp -93.85 -68.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.787 -171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' HD22 ' A' ' 28' ' ' ASN . . . 103.54 62.17 0.69 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.858 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 62.28 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.118 0.567 . . . . 0.0 110.825 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.98 -54.01 3.0 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.71 49.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.89 -40.56 79.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.11 0.481 . . . . 0.0 111.18 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.6 m-80 -89.3 -23.79 22.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.579 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.5 m -65.85 -31.72 54.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.39 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -75.52 -20.72 58.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.767 0.318 . . . . 0.0 110.312 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.0 -37.68 54.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 29' ' ' VAL . 39.8 mt -56.04 -45.28 80.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.91 -45.59 86.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.115 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.8 pt20 -68.64 -27.55 66.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.672 0.272 . . . . 0.0 110.929 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 80.2 mm-40 -79.23 -31.7 43.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.092 0.472 . . . . 0.0 110.583 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 39.9 p -105.93 -74.31 0.66 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -170.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.78 -26.54 2.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.93 148.21 23.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 0.0 110.818 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -87.82 123.3 32.46 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.569 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 22.0 t -97.01 92.41 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.77 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -99.21 158.66 15.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.929 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.455 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 1.6 mt -90.3 126.47 43.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 32.8 t -78.12 151.57 33.26 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.444 0.64 . . . . 0.0 112.209 -168.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -98.4 -6.7 30.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.078 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' O ' HD13 ' A' ' 56' ' ' LEU . 16.0 mp0 -87.24 169.3 12.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.373 -176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.83 150.55 50.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.724 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.94 ' HD3' HD11 ' A' ' 56' ' ' LEU . 93.3 Cg_endo -84.64 166.23 11.92 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.524 2.149 . . . . 0.0 111.591 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.08 -2.37 2.95 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.137 2.558 . . . . 0.0 113.188 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -95.41 -19.06 20.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 110.697 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.19 25.8 72.37 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.656 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.441 ' OD1' ' HB3' ' A' ' 53' ' ' ASN . 9.0 t70 -107.97 124.11 35.74 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.433 0.159 . . . . 0.0 110.594 -175.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -85.3 2.75 7.65 Favored 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 123.124 2.549 . . . . 0.0 113.526 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 11.7 t30 -82.05 -4.14 56.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.191 0.996 . . . . 0.0 109.098 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -114.46 95.05 5.06 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.543 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 13' ' ' ILE . 11.9 tptt -77.58 109.11 11.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.591 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.94 HD11 ' HD3' ' A' ' 47' ' ' PRO . 4.9 mp -74.94 144.55 43.17 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.616 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -124.99 133.3 53.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.833 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.5 mt -99.11 119.59 47.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.693 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.656 HD11 HD12 ' A' ' 73' ' ' ILE . 69.5 mt -99.64 101.52 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.05 142.84 43.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.406 0.622 . . . . 0.0 111.455 -171.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.16 -151.38 23.36 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.674 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.3 m -82.88 141.61 44.2 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -41.14 -47.83 5.1 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.663 2.909 . . . . 0.0 114.221 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -70.22 -22.42 62.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.774 0.321 . . . . 0.0 111.667 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 96.5 mt-30 -79.45 -47.05 16.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.486 HG23 ' HB ' ' A' ' 59' ' ' ILE . 42.8 mt -54.28 -55.97 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.058 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.84 -34.79 78.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 110.576 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 72' ' ' LEU . 11.6 t-160 -59.4 -51.11 71.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.668 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.88 -43.57 94.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.616 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -49.67 -41.19 42.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.308 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -67.62 -49.64 61.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.287 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.8 mp -56.46 -42.02 77.51 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.793 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.992 HG23 HG11 ' A' ' 21' ' ' VAL . 39.5 mt -63.44 -45.58 97.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 111.155 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -62.98 -24.0 67.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.51 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.18 -29.03 22.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.594 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB2' HG13 ' A' ' 21' ' ' VAL . 12.7 mmmm -63.01 -43.8 97.76 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.249 0.547 . . . . 0.0 109.681 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG22 HD11 ' A' ' 20' ' ' LEU . 35.8 pt -86.93 -18.16 8.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.805 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 59.74 46.48 11.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.527 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.21 164.35 31.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.028 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.48 132.34 5.84 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.783 2.322 . . . . 0.0 112.905 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 37.0 mt -108.7 134.94 50.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.837 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 1.8 p -101.0 139.8 20.79 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.789 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 21.1 Cg_exo -65.77 118.38 5.43 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.791 2.327 . . . . 0.0 111.212 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.99 129.89 61.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.199 0.523 . . . . 0.0 111.91 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 169.759 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HG3' ' CB ' ' A' ' 60' ' ' ARG . 5.6 mp0 -94.47 83.99 4.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 111.445 0.165 . . . . 0.0 111.445 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB2' HG21 ' A' ' 66' ' ' ILE . 0.4 OUTLIER -72.38 130.19 40.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -114.18 130.62 56.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.066 0.46 . . . . 0.0 111.715 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.76 179.57 4.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.183 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -110.04 119.73 40.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.416 . . . . 0.0 111.46 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.545 HG21 HD11 ' A' ' 22' ' ' ILE . 12.9 mm -112.52 114.35 50.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.623 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 65.8 Cg_exo -50.39 133.6 37.17 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.246 2.63 . . . . 0.0 112.96 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 m -62.69 -26.63 68.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.509 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -76.83 -17.42 59.01 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.024 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 21' ' ' VAL . 25.5 mtmt -99.75 5.8 45.58 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.297 -0.252 . . . . 0.0 111.187 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.073 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.1 p -72.12 7.07 1.82 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.039 0.447 . . . . 0.0 111.204 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.77 -33.53 2.22 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.833 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.649 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -81.45 -32.28 32.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 117.415 0.608 . . . . 0.0 111.287 -175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.987 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.87 -27.14 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.196 0.522 . . . . 0.0 110.906 178.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.073 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -100.65 -47.38 11.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.722 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.34 -135.01 13.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.673 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 20.3 ptt180 -90.85 99.93 12.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.15 -54.58 3.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.391 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.96 37.42 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.53 -39.72 81.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.07 0.462 . . . . 0.0 110.319 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.91 -26.08 53.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.777 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.717 HG23 ' HA ' ' A' ' 22' ' ' ILE . 61.4 t -72.33 -34.88 50.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.365 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.74 -20.0 63.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.944 0.402 . . . . 0.0 110.294 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.71 -29.91 51.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.102 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' CD1' ' HA ' ' A' ' 29' ' ' VAL . 22.4 mt -59.84 -44.99 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -58.27 -51.49 69.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.836 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -62.28 -28.59 69.83 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.8 mm-40 -79.54 -25.69 41.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.439 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 69' ' ' ALA . 61.8 p -110.47 -76.07 0.61 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -171.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.4 -23.73 1.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 151.73 21.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.8 0.333 . . . . 0.0 110.838 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -92.2 109.13 20.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.958 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 59' ' ' ILE . 20.2 t -95.09 123.63 47.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.1 pt-20 -135.42 -177.25 4.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.139 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.84 141.07 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.406 ' HB2' HG13 ' A' ' 58' ' ' ILE . 27.0 t -98.64 160.02 14.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.518 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.6 5.75 19.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.807 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.534 ' HB2' HD22 ' A' ' 56' ' ' LEU . 97.2 mt-30 -89.09 154.67 19.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.895 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.05 150.66 36.97 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.13 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.66 172.14 14.98 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 110.799 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.554 ' HD3' HG13 ' A' ' 84' ' ' VAL . 25.8 Cg_exo -63.48 -1.18 2.93 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.724 2.283 . . . . 0.0 112.868 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 49' ' ' ASN . 0.9 OUTLIER -99.15 -20.2 16.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.615 176.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.79 21.96 73.41 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.939 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.86 135.0 24.06 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -78.77 4.25 6.6 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.058 2.505 . . . . 0.0 113.229 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -93.92 3.75 54.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.049 0.452 . . . . 0.0 110.797 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.21 89.26 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.03 172.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -82.93 128.94 34.91 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.151 0.5 . . . . 0.0 110.107 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD21 HG11 ' A' ' 84' ' ' VAL . 10.3 mp -69.14 146.48 52.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.251 0.548 . . . . 0.0 111.373 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.498 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.49 139.09 53.39 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.069 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.583 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -104.9 130.57 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.353 -176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 HG22 ' A' ' 40' ' ' VAL . 47.5 mt -121.25 98.14 5.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 170.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.725 ' CB ' ' HG3' ' A' ' 8' ' ' GLU . 10.3 ptm180 -98.29 128.17 44.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.381 0.61 . . . . 0.0 111.257 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.95 -112.53 0.47 Allowed Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.123 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.6 m -141.33 151.04 60.18 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -40.63 -50.01 4.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.759 2.973 . . . . 0.0 114.443 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -70.79 -33.64 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.2 -43.7 27.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 9' ' ' MET . 74.0 mt -58.42 -52.22 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.168 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.98 -35.47 80.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.292 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.604 ' O ' HD12 ' A' ' 72' ' ' LEU . 16.3 t-160 -61.57 -50.75 71.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.736 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.3 -45.38 88.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 110.7 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -51.65 -40.8 60.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.186 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.08 -50.67 67.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.7 mp -55.48 -38.96 69.8 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 176.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.987 HG23 HG11 ' A' ' 21' ' ' VAL . 55.6 mt -68.46 -41.75 83.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.79 0.329 . . . . 0.0 110.462 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 66.9 mt-10 -67.34 -17.23 64.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.956 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -84.89 -34.6 22.54 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 32.1 mmtp -64.82 -52.55 56.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.342 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 29.7 pt -84.24 -15.47 11.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.551 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 62.28 34.43 15.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.181 177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.482 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -150.6 152.34 24.21 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -71.65 133.73 22.72 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.459 2.106 . . . . 0.0 112.758 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.77 150.04 20.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 52.9 t -109.09 130.76 22.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.706 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.6 137.35 38.8 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.684 2.256 . . . . 0.0 110.609 172.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.629 HG11 HD21 ' A' ' 56' ' ' LEU . 48.2 t -105.84 -72.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.259 -176.77 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 2.1 mp0 -90.44 116.29 28.26 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.718 0.294 . . . . 0.0 110.337 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.78 124.7 46.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -106.76 136.32 46.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -122.92 179.59 4.6 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 t -112.75 118.68 35.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.882 0.372 . . . . 0.0 110.269 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.756 HG21 HD11 ' A' ' 22' ' ' ILE . 10.0 mm -121.11 116.98 30.91 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.438 0.637 . . . . 0.0 111.449 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.616 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 29.1 Cg_exo -47.75 137.38 21.29 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.981 3.121 . . . . 0.0 113.159 171.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.7 m -63.4 -29.87 71.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.407 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -72.49 -20.06 61.44 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.941 -0.475 . . . . 0.0 110.88 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 38.7 mtmt -93.03 7.05 45.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.994 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.7 p -79.81 25.17 0.36 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.128 0.489 . . . . 0.0 111.838 -176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.65 -31.97 0.79 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.732 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 HG22 ' A' ' 77' ' ' ILE . 4.3 pp -81.52 -25.94 35.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.444 0.164 . . . . 0.0 111.23 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.954 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.5 -31.01 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.868 173.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.994 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.1 mp -96.1 -64.22 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.775 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.13 -170.99 27.93 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.829 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -60.35 97.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.72 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.61 -54.71 3.72 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.628 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.52 55.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 40.6 tt0 -84.01 -37.83 21.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.0 110.677 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 32' ' ' ILE . 10.0 m120 -76.82 -28.98 55.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 22' ' ' ILE . 24.1 m -68.25 -29.42 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 17.1 ptpt -71.98 -27.43 62.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.488 . . . . 0.0 109.843 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.99 -27.8 43.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.538 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' VAL . 28.6 mt -60.55 -45.17 97.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 44.7 t-20 -54.46 -53.6 52.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.15 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 13.8 pt20 -65.21 -28.81 69.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.953 0.406 . . . . 0.0 111.362 -175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -75.39 -24.45 57.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.549 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.763 HG21 ' HA ' ' A' ' 69' ' ' ALA . 53.6 p -115.09 -72.74 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -169.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.661 ' HA3' ' NE2' ' A' ' 65' ' ' GLN . . . 148.0 -32.2 1.3 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.45 153.51 21.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.926 0.394 . . . . 0.0 110.681 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 71.3 m-85 -90.34 114.7 26.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.896 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.88 122.27 44.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.005 0.431 . . . . 0.0 110.842 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.568 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 2.1 pt-20 -135.59 177.1 8.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.966 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.22 137.8 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 18.2 t -90.94 161.87 15.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 0.0 111.723 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.768 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -106.74 11.57 30.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.944 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -87.43 156.71 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.351 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.1 mt -98.29 147.07 32.61 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 8.7 Cg_exo -70.57 170.95 16.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.479 2.119 . . . . 0.0 111.321 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.54 -34.79 53.58 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 121.937 1.758 . . . . 0.0 111.335 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -71.09 -26.53 63.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.632 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.4 31.11 79.32 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.391 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -103.68 131.21 22.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.44 -12.39 33.39 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.231 2.621 . . . . 0.0 113.992 -174.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -80.45 -15.75 56.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 88.2 m-85 -105.76 105.47 15.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -98.72 131.81 44.59 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.496 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 43' ' ' SER . 3.8 mm? -73.89 129.32 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 -175.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.779 ' HE1' HG13 ' A' ' 22' ' ' ILE . 9.6 t80 -107.32 125.02 50.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.751 -173.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 30.5 mt -103.82 129.67 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.977 0.418 . . . . 0.0 111.575 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.4 mt -122.38 105.62 16.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 168.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.567 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.1 ptm180 -104.42 126.18 51.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.107 0.479 . . . . 0.0 111.157 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.43 -157.51 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.0 m -81.7 145.52 54.5 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -40.12 -50.65 3.43 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.545 2.83 . . . . 0.0 113.578 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -56.42 -39.57 73.29 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.328 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.661 ' NE2' ' HA3' ' A' ' 37' ' ' GLY . 9.7 mm100 -78.01 -40.28 39.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.013 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 59' ' ' ILE . 65.5 mt -64.95 -52.18 57.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.066 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 21.3 t70 -64.35 -35.44 80.88 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' O ' HD12 ' A' ' 72' ' ' LEU . 20.3 t-160 -61.44 -51.18 69.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 173.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.07 -42.43 76.65 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.808 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 52.0 tttt -50.61 -44.32 57.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.042 176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.865 HE21 ' HA ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -63.35 -47.86 80.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.284 -177.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.08 -42.86 73.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.922 0.391 . . . . 0.0 111.168 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.954 HG23 HG11 ' A' ' 21' ' ' VAL . 69.0 mt -64.51 -41.7 93.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.535 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 59.0 mt-10 -69.09 -13.28 62.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.053 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -89.55 -33.75 16.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 65.6 mmtt -66.31 -47.11 74.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.935 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 20' ' ' LEU . 24.3 pt -90.75 -16.84 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.909 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.6 mt-10 53.37 50.69 16.93 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.727 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -159.27 144.19 9.97 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.337 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 16.1 Cg_exo -68.9 128.32 16.64 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.256 2.637 . . . . 0.0 112.533 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 81' ' ' LEU . 24.5 mt -97.71 146.87 24.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.545 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 46.0 t -111.29 128.12 25.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.454 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 18.3 Cg_exo -67.32 125.1 12.95 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.724 2.283 . . . . 0.0 111.663 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.42 -78.41 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.796 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 10' ' ' THR . . . . . . . . 0 CA--C 1.519 0.312 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.126 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 120.909 0.172 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.719 ' HG3' ' HB3' ' A' ' 60' ' ' ARG . 14.6 mp0 -91.48 144.86 25.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.789 0.328 . . . . 0.0 111.031 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.684 ' HB2' HG21 ' A' ' 66' ' ' ILE . 24.1 mmt -120.09 119.64 33.92 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 16.8 m -99.17 143.17 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.846 0.355 . . . . 0.0 110.524 -176.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -130.04 173.71 10.47 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -108.24 117.08 33.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.741 0.305 . . . . 0.0 110.857 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 22' ' ' ILE . 25.9 mm -111.44 111.35 55.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.4 0.619 . . . . 0.0 110.807 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 12.4 Cg_exo -43.57 137.51 5.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.864 3.043 . . . . 0.0 114.173 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.6 m -59.53 -17.83 35.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.84 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -93.17 -19.85 21.05 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.928 -0.483 . . . . 0.0 111.491 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 24.4 mtmt -95.62 6.48 48.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.224 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.931 ' HA ' HD13 ' A' ' 22' ' ' ILE . 23.8 p -72.51 17.59 0.11 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.219 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -123.69 -36.58 0.63 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.266 177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 77' ' ' ILE . 3.3 pp -79.91 -38.5 32.37 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 122.556 -0.379 . . . . 0.0 111.131 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.075 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -94.85 -24.08 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 121.319 0.58 . . . . 0.0 110.553 178.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.931 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -95.04 -64.88 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.156 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA3' ' H ' ' A' ' 27' ' ' GLU . . . 122.49 -168.06 14.93 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.811 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -68.79 -54.51 15.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.247 0.546 . . . . 0.0 109.712 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.36 32.46 3.92 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.7 42.94 5.28 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 21.4 tp10 -68.25 -35.48 77.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 32' ' ' ILE . 11.7 t30 -87.16 -41.31 13.86 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.242 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.729 HG13 ' HA ' ' A' ' 22' ' ' ILE . 35.3 m -63.54 -31.75 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 63.0 pttt -68.81 -33.12 73.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.096 0.474 . . . . 0.0 110.266 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -77.65 -31.88 52.91 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.452 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 29' ' ' VAL . 57.8 mt -54.87 -46.77 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -55.68 -48.79 74.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.559 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 16.9 mt-30 -59.62 -38.75 82.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.148 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 78.2 mm-40 -72.95 -27.6 61.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.328 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -113.44 -65.36 1.19 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.17 -16.03 5.52 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.56 147.78 23.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.189 0.519 . . . . 0.0 111.368 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 91.8 m-85 -88.37 107.07 18.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.206 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.1 t -87.18 85.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.445 0.641 . . . . 0.0 109.566 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.603 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 6.5 mm-40 -91.56 148.52 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.918 -174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.444 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 8.7 mt -79.37 118.36 26.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.7 t -78.41 151.39 32.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.514 0.673 . . . . 0.0 111.533 -170.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.116 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.53 142.42 27.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.799 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 mt -97.2 153.86 38.31 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.63 173.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.54 160.91 45.8 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.255 1.97 . . . . 0.0 110.066 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.91 44.38 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.702 0 C-N-CA 123.317 2.678 . . . . 0.0 113.642 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -147.8 -14.57 0.37 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.661 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.03 36.38 72.54 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -171.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.6 t70 -87.25 121.81 71.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.362 -174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 5.7 Cg_endo -85.03 1.16 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.355 2.703 . . . . 0.0 113.091 -176.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -87.51 -11.11 49.86 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.408 0.623 . . . . 0.0 110.177 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.08 122.23 33.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.744 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -105.29 119.29 38.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.93 156.85 38.48 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.972 0.415 . . . . 0.0 110.651 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -131.52 134.34 46.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.239 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 11.0 mt -98.4 110.08 25.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.409 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' HG23 ' A' ' 66' ' ' ILE . 43.3 mt -99.67 100.41 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . 18.5 ptt180 -109.0 132.57 53.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.032 -174.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.92 -162.63 31.82 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.501 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.7 m -69.82 148.91 96.62 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.675 0.238 . . . . 0.0 110.386 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 -52.73 5.81 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.454 2.769 . . . . 0.0 113.845 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -66.39 -25.8 66.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.916 0.389 . . . . 0.0 111.213 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.7 mt-30 -77.76 -43.09 31.86 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.684 HG21 ' HB2' ' A' ' 9' ' ' MET . 23.7 mt -61.81 -55.33 24.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.59 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.28 -38.83 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.208 -175.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.7 t-160 -65.72 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.22 -43.02 83.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.082 0.467 . . . . 0.0 109.987 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -53.84 -47.1 71.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.639 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -65.46 -31.71 72.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.591 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 52.1 mt -65.85 -34.75 78.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 176.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.075 HG23 HG11 ' A' ' 21' ' ' VAL . 73.4 mt -73.56 -45.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.668 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 72.7 mt-10 -61.18 -27.89 68.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.373 176.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 72' ' ' LEU . 6.2 tp10 -65.3 -45.63 83.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.22 0.534 . . . . 0.0 110.138 171.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.1 mmtm -64.11 -49.83 70.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 20' ' ' LEU . 35.4 pt -89.84 -3.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.744 -173.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 40.53 48.71 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.188 0.93 . . . . 0.0 111.723 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.58 160.58 30.35 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.05 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 91.6 Cg_endo -81.94 147.25 14.95 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.55 2.166 . . . . 0.0 112.893 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.54 139.68 48.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 7.4 p -97.45 131.35 27.37 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 20.4 Cg_exo -66.8 101.48 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.167 2.578 . . . . 0.0 112.354 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 10' ' ' THR . 17.9 t -99.35 156.34 3.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.412 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.11 134.05 35.31 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.435 ' HB3' HG21 ' A' ' 66' ' ' ILE . 11.3 tpt -108.04 133.44 52.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.312 -175.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.647 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 7.2 m -108.95 134.7 51.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.934 0.397 . . . . 0.0 111.58 -176.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -127.04 158.75 36.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.036 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB3' HG21 ' A' ' 84' ' ' VAL . 51.0 p -86.9 110.03 19.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.415 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 22' ' ' ILE . 14.5 mm -110.31 113.38 56.43 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 121.247 0.546 . . . . 0.0 110.887 176.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HB3' ' CE1' ' A' ' 16' ' ' HIS . 89.3 Cg_exo -54.25 129.69 35.85 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.121 2.547 . . . . 0.0 112.623 173.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.4 m -58.82 -29.92 67.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.632 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.448 ' CE1' ' HB3' ' A' ' 14' ' ' PRO . 47.7 p-80 -77.61 -17.76 57.48 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.262 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 31.7 mtmt -96.76 8.85 43.36 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.074 -0.251 . . . . 0.0 111.64 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.016 ' HA ' HD13 ' A' ' 22' ' ' ILE . 20.2 p -71.99 18.93 0.07 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.019 0.437 . . . . 0.0 111.804 -176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -121.43 -35.29 0.81 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.42 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 77' ' ' ILE . 3.4 pp -84.36 -20.39 32.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.939 0.37 . . . . 0.0 111.076 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG13 ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -114.35 -26.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.843 0.354 . . . . 0.0 111.135 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.016 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.9 mp -105.83 -68.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.684 -173.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 97.15 0.54 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.472 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 60.5 -98.07 0.08 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.967 0.507 . . . . 0.0 111.212 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.44 14.74 17.97 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 113.78 44.94 0.73 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.629 177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.719 ' HA ' ' HE3' ' A' ' 30' ' ' LYS . 11.9 tp10 -74.57 -21.6 59.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.266 0.555 . . . . 0.0 109.938 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -92.46 -43.21 9.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.22 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.679 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.5 m -65.06 -27.92 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.046 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.719 ' HE3' ' HA ' ' A' ' 27' ' ' GLU . 17.3 ptpt -66.77 -34.18 77.25 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.48 -37.52 77.3 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 29' ' ' VAL . 19.4 mt -56.48 -49.43 77.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 4.9 t-20 -52.99 -45.08 67.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.278 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.915 HE21 ' HA ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -63.13 -45.39 92.17 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 11.3 mm100 -70.42 -26.49 63.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.512 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.723 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -106.0 -81.1 0.55 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.38 -39.08 0.76 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -173.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.33 153.21 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.775 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 96.9 m-85 -91.68 121.96 33.8 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.667 HG12 ' CE2' ' A' ' 57' ' ' PHE . 4.6 t -92.76 92.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 51.9 mm-40 -95.37 144.86 25.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.434 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 23.5 mt -83.67 127.2 39.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 170.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.546 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . 17.4 t -95.48 174.38 7.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.439 0.638 . . . . 0.0 111.069 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.539 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.02 10.03 13.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.37 177.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' HB2' HD12 ' A' ' 56' ' ' LEU . 31.7 mm-40 -91.09 142.37 27.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.653 177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 56.4 mt -96.23 147.23 32.65 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' ASN . 18.0 Cg_endo -59.99 159.86 24.15 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.752 . . . . 0.0 109.55 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.06 7.73 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.158 2.572 . . . . 0.0 112.982 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' PRO . 11.3 m120 -98.5 -21.04 16.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.249 0.547 . . . . 0.0 110.056 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.74 34.0 87.57 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.601 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.72 124.06 64.89 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.686 0.243 . . . . 0.0 110.825 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.17 -12.25 33.57 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.873 2.382 . . . . 0.0 112.334 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -87.33 -0.97 57.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.347 0.594 . . . . 0.0 110.178 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -130.26 116.12 17.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.168 0.509 . . . . 0.0 110.695 177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -108.18 137.78 45.58 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.33 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 19.0 mt -73.74 137.82 44.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.667 ' CE2' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -114.66 132.01 56.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 43' ' ' SER . 1.6 mt -102.14 107.47 21.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.707 -174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 ' HB ' HG23 ' A' ' 66' ' ' ILE . 35.4 mt -93.15 95.2 5.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 14.9 ptm180 -96.16 140.56 30.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.779 -174.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.02 -123.58 1.42 Allowed Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.494 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.7 p -132.12 147.72 66.92 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.68 -41.63 5.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.429 2.753 . . . . 0.0 113.993 -174.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.6 -42.98 91.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.524 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -78.33 -39.58 39.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.299 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 59' ' ' ILE . 58.1 mt -56.62 -55.26 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.22 -35.46 77.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.093 0.473 . . . . 0.0 110.835 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.595 ' O ' HD12 ' A' ' 72' ' ' LEU . 23.7 t-160 -61.91 -51.14 69.36 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.87 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -61.38 -43.46 98.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.729 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.65 -32.32 65.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -68.22 -47.68 67.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.502 0.191 . . . . 0.0 110.722 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -59.11 -36.79 75.77 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG23 HG11 ' A' ' 21' ' ' VAL . 69.4 mt -64.99 -45.56 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.378 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -65.29 -13.96 59.65 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.316 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -86.41 -36.71 18.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HB2' HG13 ' A' ' 21' ' ' VAL . 29.6 mmtp -65.99 -45.76 80.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.252 0.549 . . . . 0.0 109.816 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.62 HG13 ' H ' ' A' ' 79' ' ' GLY . 22.4 pt -88.32 -17.58 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.907 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 62.32 31.17 17.48 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.032 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.62 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -146.16 147.52 18.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.22 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.484 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 11.2 Cg_exo -70.91 132.42 21.45 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.057 2.505 . . . . 0.0 112.192 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -96.02 138.56 33.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.008 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.1 t -91.26 134.71 29.29 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.177 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 22.6 Cg_exo -65.76 129.24 21.69 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.824 2.349 . . . . 0.0 111.307 174.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.647 ' O ' ' HB ' ' A' ' 10' ' ' THR . 5.4 t -126.47 149.33 31.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.56 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.685 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 175.47 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.45 136.16 33.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 0.0 110.528 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.741 ' HB2' HG21 ' A' ' 66' ' ' ILE . 1.1 mpt? -113.9 108.22 16.76 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 172.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 6.2 m -89.6 139.28 30.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.757 -178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -128.22 136.27 50.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 54' ' ' PHE . 10.0 t -79.3 117.88 20.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.739 0.304 . . . . 0.0 110.727 -176.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 22' ' ' ILE . 12.0 mt -113.51 129.11 24.96 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.388 0.613 . . . . 0.0 111.094 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 65.3 Cg_exo -50.89 131.61 34.89 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.391 2.727 . . . . 0.0 113.225 174.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -57.51 -29.97 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.007 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -75.16 -15.67 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' HZ1' HD12 ' A' ' 77' ' ' ILE . 33.5 mtmt -99.04 9.03 44.38 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 120.855 0.36 . . . . 0.0 111.967 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.933 ' HA ' HD13 ' A' ' 22' ' ' ILE . 25.3 p -69.98 10.79 0.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.108 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.18 -41.07 0.6 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.927 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -73.27 -29.63 62.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.862 0.331 . . . . 0.0 111.579 -178.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -108.45 -38.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.358 0.599 . . . . 0.0 110.963 176.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.933 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -87.37 -71.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.114 -174.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.39 53.86 1.12 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.588 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 65.41 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.536 0.735 . . . . 0.0 111.647 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -94.13 -14.31 51.92 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.531 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.56 55.08 0.36 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.072 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -84.84 -33.13 22.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.691 0.281 . . . . 0.0 111.209 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 26.8 t-20 -84.32 -32.27 24.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.258 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.644 HG13 ' HA ' ' A' ' 22' ' ' ILE . 34.0 m -63.01 -26.5 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 23.0 pttp -75.98 -20.55 57.79 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.551 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.5 61.68 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 29' ' ' VAL . 44.4 mt -56.03 -43.62 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 26.8 t-20 -57.43 -47.62 81.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.262 176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 23.2 mm-40 -60.03 -36.42 77.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.369 0.604 . . . . 0.0 110.766 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -72.17 -29.11 63.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.423 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.419 HG21 ' CA ' ' A' ' 69' ' ' ALA . 41.3 p -115.9 -69.76 0.84 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -167.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.4 -17.61 4.0 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.87 150.88 21.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.2 m-85 -87.86 116.76 26.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.367 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 5.4 t -95.23 97.71 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 18.9 mm-40 -106.31 152.26 23.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.313 -170.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.657 HG13 ' CZ ' ' A' ' 57' ' ' PHE . 3.8 mp -84.4 122.49 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' HB2' HG13 ' A' ' 58' ' ' ILE . 13.0 t -80.35 157.44 26.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 112.1 -170.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -106.31 3.38 27.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.419 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -86.17 132.05 34.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.63 149.21 35.53 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.644 ' HG2' ' H ' ' A' ' 51' ' ' ASP . 63.9 Cg_endo -73.98 167.21 27.77 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.369 2.046 . . . . 0.0 111.778 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.5 -43.48 27.34 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.729 2.286 . . . . 0.0 112.92 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -73.1 -10.66 60.02 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.966 0.412 . . . . 0.0 111.66 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.38 36.27 91.37 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -174.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' PRO . 10.2 t0 -84.08 120.36 74.63 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.381 . . . . 0.0 111.014 -172.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.6 -2.34 10.4 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.03 2.487 . . . . 0.0 112.862 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -93.04 -16.79 24.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.391 0.615 . . . . 0.0 109.734 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 85.6 m-85 -119.01 91.42 3.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.156 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -83.98 128.06 34.29 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.342 0.591 . . . . 0.0 110.355 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 11.0 mp -69.39 146.92 51.69 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.41 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.657 ' CZ ' HG13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -128.08 128.25 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.799 178.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 43' ' ' SER . 19.9 mt -92.97 119.26 40.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.63 -173.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 66' ' ' ILE . 41.6 mt -107.06 99.92 9.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HE ' ' HG3' ' A' ' 41' ' ' GLU . 23.0 ptt180 -106.19 134.68 48.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.196 -174.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.23 -146.6 14.28 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.3 m -92.69 141.91 25.05 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -40.66 -50.43 3.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.6 2.867 . . . . 0.0 114.098 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 76.5 mm-40 -65.62 -26.83 68.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -81.83 -44.12 17.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.741 HG21 ' HB2' ' A' ' 9' ' ' MET . 41.3 mt -58.27 -56.05 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.781 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 25.2 t70 -66.85 -30.84 71.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.804 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.58 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 3.0 t-160 -69.08 -38.35 78.95 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 176.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -64.38 -44.22 92.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.706 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 14.4 ttpt -51.7 -48.72 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.323 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.66 -38.42 81.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.237 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.601 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 53.3 mt -65.23 -44.88 86.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.99 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.995 HG23 HG11 ' A' ' 21' ' ' VAL . 54.7 mt -60.73 -44.99 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.326 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.19 -18.37 65.25 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.326 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.56 -34.75 19.83 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 29.6 mmmt -64.24 -49.86 70.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.446 0.641 . . . . 0.0 109.796 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 73' ' ' ILE . 10.4 pt -89.25 -14.22 9.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.952 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 57.97 50.29 10.49 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.627 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 80' ' ' PRO . . . -168.49 142.03 7.16 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.774 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 79' ' ' GLY . 16.8 Cg_exo -67.7 140.37 51.19 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.359 2.706 . . . . 0.0 112.804 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.7 mt -101.76 149.63 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.052 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 70.6 m -96.12 125.75 46.98 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.736 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 17.2 Cg_exo -68.39 128.09 16.77 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.157 2.571 . . . . 0.0 112.439 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 10' ' ' THR . 34.8 t -128.33 145.14 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.182 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.176 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.179 0 N-CA-C 113.291 0.077 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -85.3 167.46 15.59 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.046 0.451 . . . . 0.0 111.655 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.74 ' HB2' HG21 ' A' ' 66' ' ' ILE . 89.5 mtp -136.05 116.61 13.83 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 46.4 m -90.58 137.41 32.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.853 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.5 154.7 38.8 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.2 p -88.48 116.01 26.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.463 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.897 HG21 HD11 ' A' ' 22' ' ' ILE . 23.2 mm -115.74 112.6 42.82 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.117 0.484 . . . . 0.0 111.64 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.483 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 18.9 Cg_exo -48.3 132.96 24.62 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.895 3.063 . . . . 0.0 113.915 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 55' ' ' LYS . 11.2 m -76.07 63.64 1.83 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 110.831 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -170.29 -26.86 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.483 ' HE2' ' HG2' ' A' ' 14' ' ' PRO . 37.6 mtmt -88.44 7.96 30.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.402 170.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.037 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.0 p -77.75 22.87 0.25 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.766 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -123.64 -35.02 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 173.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD12 HG22 ' A' ' 21' ' ' VAL . 2.3 pp -77.78 -25.94 49.41 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.631 0.253 . . . . 0.0 111.14 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.958 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -112.69 -24.0 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.693 174.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.037 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.9 mp -109.52 -68.33 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.431 -172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.2 -148.01 16.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.284 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -81.31 -62.05 1.77 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.01 -34.3 4.04 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.7 46.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.135 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.87 -42.48 90.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.147 0.499 . . . . 0.0 110.553 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 32' ' ' ILE . 47.1 m-80 -71.07 -39.57 72.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 22' ' ' ILE . 25.2 m -67.69 -34.7 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -79.39 -21.63 45.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.175 178.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -69.98 -39.07 76.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 29' ' ' VAL . 46.4 mt -56.33 -44.93 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 37.5 t30 -54.14 -50.23 67.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.981 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 43.7 mt-30 -60.67 -35.39 76.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.963 0.411 . . . . 0.0 110.819 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 28.6 mm-40 -73.23 -32.15 64.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.1 p -107.87 -73.81 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.55 -22.08 2.2 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.83 144.42 25.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.095 0.474 . . . . 0.0 111.01 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -84.18 111.64 19.54 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.664 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.34 99.18 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.435 0.636 . . . . 0.0 110.228 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 1.8 pt-20 -116.38 -175.74 2.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.868 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -104.19 143.04 16.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.16 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 56' ' ' LEU . 23.9 t -95.13 165.95 12.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.38 0.61 . . . . 0.0 111.81 -172.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 0.62 16.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.949 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -79.41 159.71 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.388 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.13 137.47 19.71 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.602 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.573 ' HD3' HD21 ' A' ' 56' ' ' LEU . 77.7 Cg_endo -75.5 166.37 28.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.852 2.368 . . . . 0.0 111.886 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.96 -12.28 21.79 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.055 2.503 . . . . 0.0 112.104 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -87.7 -16.76 33.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.618 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 59.34 34.58 81.12 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.815 -175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 53' ' ' ASN . 15.5 t70 -124.15 127.14 25.43 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.58 0.229 . . . . 0.0 110.682 -174.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.55 -7.9 19.01 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.965 2.444 . . . . 0.0 113.493 -175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 62.2 t30 -77.87 -4.48 46.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.55 0.69 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -108.27 106.54 16.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.488 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 44.4 mmtm -79.88 112.31 17.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.21 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD21 ' HD3' ' A' ' 47' ' ' PRO . 3.4 mm? -73.88 132.09 42.16 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.3 m-85 -117.31 128.5 55.12 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.181 0.515 . . . . 0.0 111.471 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.523 ' HB ' ' HG3' ' A' ' 41' ' ' GLU . 51.8 mt -89.44 114.7 27.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.363 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 66' ' ' ILE . 60.0 mt -104.19 107.82 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . 9.7 ptm180 -116.76 129.66 56.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.203 0.525 . . . . 0.0 111.441 -172.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.89 -148.47 16.51 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.1 t -74.68 147.86 84.78 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.95 -52.91 6.99 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.108 2.539 . . . . 0.0 113.167 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 9.3 mm100 -77.75 -10.19 59.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -80.19 -45.55 17.87 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.74 HG21 ' HB2' ' A' ' 9' ' ' MET . 55.9 mt -59.48 -55.08 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.04 176.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.2 -33.33 75.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.838 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.663 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 3.0 t-160 -67.61 -46.02 73.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -59.15 -45.64 90.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -57.36 -32.39 66.73 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.159 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 68' ' ' HIS . 36.9 tt0 -64.81 -49.54 70.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.161 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -55.14 -42.13 72.64 Favored 'General case' 0 CA--C 1.524 -0.046 0 CA-C-O 120.79 0.329 . . . . 0.0 110.418 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.958 HG23 HG11 ' A' ' 21' ' ' VAL . 55.5 mt -63.02 -48.81 86.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.13 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.04 -30.7 69.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.065 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -74.22 -36.92 63.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.17 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 25.8 mmtp -61.41 -49.2 77.82 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.269 0.557 . . . . 0.0 110.059 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.736 HG22 HD11 ' A' ' 20' ' ' LEU . 29.6 pt -92.42 3.91 7.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.682 -173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 43.6 45.16 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.224 1.01 . . . . 0.0 112.319 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.31 141.41 7.2 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.366 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.03 139.03 29.22 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.816 2.344 . . . . 0.0 112.325 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.35 175.47 5.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.985 0.422 . . . . 0.0 111.531 -177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 84.3 m -123.62 136.71 27.58 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 4.5 Cg_exo -74.79 112.37 3.54 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.992 2.461 . . . . 0.0 112.166 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.588 ' O ' ' HB ' ' A' ' 10' ' ' THR . 39.6 t -101.13 117.39 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.201 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.302 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 66' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.38 -0.122 . . . . 0.0 113.059 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 11.5 pt-20 -91.93 143.4 26.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.902 0.382 . . . . 0.0 111.462 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.514 ' HB2' HG21 ' A' ' 66' ' ' ILE . 15.0 mmt -114.83 138.09 51.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.629 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 8.2 m -102.82 139.89 37.8 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.283 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.99 167.84 15.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.29 111.48 24.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.221 -173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 22' ' ' ILE . 28.4 mm -117.15 111.38 40.5 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.509 -176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 8.4 Cg_exo -43.9 138.67 6.08 Favored 'Trans proline' 0 N--CA 1.475 0.4 0 C-N-CA 124.403 3.402 . . . . 0.0 114.693 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 55' ' ' LYS . 7.2 m -74.32 47.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.691 0.758 . . . . 0.0 111.009 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -157.52 -26.26 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.228 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.584 ' HZ2' ' HB ' ' A' ' 77' ' ' ILE . 32.9 mtmt -83.37 1.3 42.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.024 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.01 ' HA ' HD13 ' A' ' 22' ' ' ILE . 26.4 p -73.74 58.71 0.63 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.904 0.859 . . . . 0.0 109.55 174.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.31 -45.7 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.826 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD12 HG22 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -75.82 -37.91 58.64 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-O 120.583 0.23 . . . . 0.0 110.974 176.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.647 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.51 -34.85 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.094 0.473 . . . . 0.0 110.592 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.01 HD13 ' HA ' ' A' ' 18' ' ' CYS . 1.4 mp -88.58 -75.01 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.336 -174.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.94 86.93 1.24 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.863 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? 54.94 -101.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.98 0.512 . . . . 0.0 111.048 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.03 46.3 1.32 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' CA ' HG22 ' A' ' 29' ' ' VAL . . . 65.68 41.64 95.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.14 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.07 -35.48 73.43 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.754 0.422 . . . . 0.0 110.594 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 64.3 t30 -93.62 -27.1 16.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG13 ' HA ' ' A' ' 22' ' ' ILE . 16.6 m -73.07 -36.02 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.313 -177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 5.2 ptpp? -68.09 -16.74 64.15 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.12 177.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.635 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.58 -33.33 47.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 73' ' ' ILE . 15.5 mt -58.8 -49.41 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -51.15 -44.89 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.421 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 20.7 pt20 -73.01 -26.01 61.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.975 0.416 . . . . 0.0 110.844 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 83.6 mm-40 -85.37 -20.59 29.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.396 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.601 HG21 ' HA ' ' A' ' 69' ' ' ALA . 46.7 p -112.91 -55.06 2.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -169.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.05 -18.45 21.5 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.19 148.07 23.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 110.589 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 95.7 m-85 -89.93 105.07 17.56 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.755 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.48 118.76 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.879 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 74.6 mm-40 -121.81 168.13 12.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.746 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 mm -97.18 117.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HD11 ' A' ' 58' ' ' ILE . 10.1 t -78.21 167.6 21.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.324 0.583 . . . . 0.0 111.125 -173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.51 ' HD3' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -116.65 8.24 13.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.196 176.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.555 ' HB2' HD12 ' A' ' 56' ' ' LEU . 46.4 mt-30 -84.99 152.91 23.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.661 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.01 136.34 20.8 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' HG ' ' A' ' 56' ' ' LEU . 17.8 Cg_endo -60.07 154.93 47.9 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 111.719 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.29 -1.24 2.85 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.145 2.563 . . . . 0.0 113.265 -175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -89.29 -16.78 30.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.88 16.19 78.21 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.293 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.04 127.19 52.64 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.795 -0.203 . . . . 0.0 110.547 -175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.85 -1.92 11.11 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.99 2.46 . . . . 0.0 113.663 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -90.02 -6.58 55.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.46 0.647 . . . . 0.0 110.181 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -116.56 94.04 4.46 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.151 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HD2' HG23 ' A' ' 15' ' ' THR . 29.9 mtpp -79.73 125.9 30.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.902 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 45' ' ' GLN . 21.1 mt -75.66 138.64 41.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.203 0.525 . . . . 0.0 110.846 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.98 147.69 42.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 18.6 mt -106.69 138.59 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.654 0.264 . . . . 0.0 110.916 -176.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' HG23 ' A' ' 66' ' ' ILE . 47.4 mt -128.26 101.64 7.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 165.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 32.4 ptt180 -107.8 133.18 52.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.753 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.27 -148.41 16.69 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.605 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.1 t -78.68 143.54 63.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.51 -21.13 44.42 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.551 2.834 . . . . 0.0 112.853 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -87.9 -26.32 22.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.555 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 90.1 mt-30 -79.23 -43.84 22.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.885 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 9' ' ' MET . 53.9 mt -58.01 -54.58 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.764 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 15.9 t70 -61.2 -37.79 84.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.232 0.539 . . . . 0.0 110.417 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.659 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.8 t-160 -63.0 -46.5 87.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.645 176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -57.22 -44.34 83.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 37.8 tttm -49.74 -43.84 48.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.959 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -60.85 -50.24 74.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -59.96 -37.98 81.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.404 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.647 HG23 HG11 ' A' ' 21' ' ' VAL . 51.2 mt -66.98 -43.95 88.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.325 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 52.8 mt-10 -62.98 -30.18 71.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.618 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.1 -42.71 75.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.158 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 74.3 mmtt -58.07 -51.2 70.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.136 0.494 . . . . 0.0 110.879 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.584 ' HB ' ' HZ2' ' A' ' 17' ' ' LYS . 25.5 pt -92.05 -1.56 10.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.826 -173.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 42.68 53.42 4.82 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.467 1.107 . . . . 0.0 111.82 -173.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.79 143.41 8.58 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.749 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 55.4 Cg_endo -70.9 141.58 40.92 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.608 2.206 . . . . 0.0 112.723 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.01 136.81 42.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 111.669 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.43 123.54 68.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.37 121.48 8.26 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.374 2.716 . . . . 0.0 113.016 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -109.59 161.53 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.739 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -1.081 . . . . 0.0 112.806 176.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.788 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 128.59 36.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.042 0.449 . . . . 0.0 110.948 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB2' HG21 ' A' ' 66' ' ' ILE . 66.6 mtt -104.89 124.63 49.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.936 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.9 m -96.05 144.77 26.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.73 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -132.4 159.57 38.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.859 0.362 . . . . 0.0 110.725 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -87.52 103.21 15.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.057 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 22' ' ' ILE . 19.5 mm -109.58 104.02 54.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.879 0.847 . . . . 0.0 111.08 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . 34.1 Cg_exo -50.35 142.85 28.4 Favored 'Trans proline' 0 C--N 1.333 -0.264 0 C-N-CA 124.138 3.225 . . . . 0.0 113.943 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.7 m -68.87 -29.13 67.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.753 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 14' ' ' PRO . 24.0 p80 -69.27 -16.36 63.56 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 42.0 mtmt -107.33 2.46 24.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.035 175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.982 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.3 p -72.13 10.76 0.68 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.651 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.13 -32.98 1.3 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.399 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 21' ' ' VAL . 3.4 pp -82.6 -24.99 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 122.552 -0.381 . . . . 0.0 111.866 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.813 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.64 -20.58 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.199 0.523 . . . . 0.0 110.678 176.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.982 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.1 mp -103.29 -55.68 5.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.527 -171.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.59 -132.99 10.24 Favored Glycine 0 N--CA 1.454 -0.132 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.411 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -92.23 -55.19 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.77 7.48 6.5 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.274 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.46 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.682 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HA ' ' HE2' ' A' ' 30' ' ' LYS . 18.5 mp0 -64.68 -49.25 71.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 110.9 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' O ' HG13 ' A' ' 32' ' ' ILE . 2.3 m-20 -68.79 -37.73 79.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.709 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 22' ' ' ILE . 8.7 t -65.63 -42.5 92.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.689 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -69.13 -28.05 66.11 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.156 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 35' ' ' GLN . . . -70.93 -34.91 71.97 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.267 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 29' ' ' VAL . 35.9 mt -54.38 -49.37 65.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -56.82 -50.36 72.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.388 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 1.5 pp0? -66.66 -34.18 77.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 111.452 -175.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.621 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 15.3 mm100 -69.5 -36.8 76.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.956 176.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 69' ' ' ALA . 52.7 p -100.94 -71.5 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -170.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.28 -19.07 3.06 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.39 -172.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -90.32 152.0 21.23 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.409 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 44.8 m-85 -96.19 107.93 20.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.557 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.706 ' HB ' HG13 ' A' ' 29' ' ' VAL . 46.9 t -89.62 105.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -104.28 159.43 15.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.749 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.33 115.8 43.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.422 ' HB2' HG13 ' A' ' 58' ' ' ILE . 11.4 t -84.2 -179.05 7.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.917 0.865 . . . . 0.0 111.734 -171.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -131.72 18.9 4.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.735 177.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' A' ' 56' ' ' LEU . 70.8 mt-30 -90.47 149.49 22.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.331 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 3.6 mm? -95.19 129.14 36.21 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.202 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 14.0 Cg_exo -68.29 160.24 49.82 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.821 2.347 . . . . 0.0 111.805 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -48.39 -43.54 32.15 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.513 2.142 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -63.6 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.548 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.55 70.39 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.73 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.05 127.87 67.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.18 -4.21 14.45 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.004 2.469 . . . . 0.0 113.702 -173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -86.55 -25.21 25.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -92.46 109.68 21.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.156 0.503 . . . . 0.0 111.233 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.79 142.62 27.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' HB2' ' A' ' 45' ' ' GLN . 48.7 mt -87.86 131.92 34.38 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 120.326 -0.549 . . . . 0.0 110.252 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.502 ' CD1' ' HB ' ' A' ' 13' ' ' ILE . 2.6 m-85 -112.45 128.87 56.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.343 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 43' ' ' SER . 5.9 mt -100.09 102.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.507 -174.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.473 HD11 HD12 ' A' ' 73' ' ' ILE . 55.2 mt -91.74 99.6 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -109.2 136.65 48.33 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.88 -171.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.24 -151.91 23.55 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.8 m -88.33 148.01 41.49 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.17 -52.24 6.72 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 113.707 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.86 -28.92 66.57 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.238 0.542 . . . . 0.0 111.204 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 24.8 mt-30 -79.6 -50.08 11.22 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.06 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG21 ' HB2' ' A' ' 9' ' ' MET . 40.4 mt -58.57 -55.03 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.14 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.95 -38.96 87.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.233 0.54 . . . . 0.0 111.103 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.649 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.4 t-160 -65.53 -47.11 77.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.969 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -56.74 -43.18 80.44 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.056 0.455 . . . . 0.0 110.465 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -51.76 -40.48 60.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.041 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -63.76 -49.57 72.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 68' ' ' HIS . 4.5 mp -57.88 -39.32 77.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 110.461 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.813 HG23 HG11 ' A' ' 21' ' ' VAL . 39.0 mt -67.33 -42.38 87.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.797 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' GLU . 61.6 mt-10 -68.78 -12.49 61.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -90.22 -27.98 19.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.036 0.446 . . . . 0.0 109.844 174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.694 ' HB2' HG13 ' A' ' 21' ' ' VAL . 28.1 mmmt -73.27 -50.71 20.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 79' ' ' GLY . 33.7 pt -82.66 -20.2 9.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.684 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 27.3 mt-10 57.19 39.43 28.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.915 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.586 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -147.18 157.27 27.35 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.277 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.31 131.77 13.12 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.481 2.121 . . . . 0.0 112.917 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 81' ' ' LEU . 22.9 mt -103.54 128.09 50.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.835 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 56.8 m -91.73 140.11 25.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 30.9 Cg_exo -63.02 105.03 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.009 2.473 . . . . 0.0 111.654 176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 10' ' ' THR . 53.6 t -106.41 144.57 15.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.362 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 C-N-CA 120.117 -1.039 . . . . 0.0 112.473 176.363 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.2 pt-20 -91.91 100.92 13.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.084 0.469 . . . . 0.0 110.524 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 42.6 tpp -77.86 133.82 38.07 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 56' ' ' LEU . 3.7 m -113.31 140.95 47.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.734 0.302 . . . . 0.0 111.091 -175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -131.6 150.83 52.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 p -91.01 108.98 20.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.758 0.313 . . . . 0.0 110.973 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 22' ' ' ILE . 6.2 mt -111.0 123.8 34.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.402 0.62 . . . . 0.0 110.91 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 20.0 Cg_exo -45.95 135.45 14.11 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 124.078 3.186 . . . . 0.0 113.751 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.3 m -63.14 -20.87 65.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.442 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -81.44 -24.33 36.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.14 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 21' ' ' VAL . 31.5 mtmt -89.71 9.2 28.05 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.824 0.345 . . . . 0.0 111.305 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 1.032 ' HA ' HD13 ' A' ' 22' ' ' ILE . 22.4 p -67.73 3.75 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.923 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.0 -39.8 1.13 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.753 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.772 HD11 HG22 ' A' ' 77' ' ' ILE . 4.2 pp -76.98 -20.06 56.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.89 0.345 . . . . 0.0 111.664 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -114.92 -31.7 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.409 173.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.032 HD13 ' HA ' ' A' ' 18' ' ' CYS . 3.4 mp -101.24 -54.31 6.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.534 -173.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 120.21 -166.74 13.62 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.54 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -59.2 -38.97 81.18 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' O ' HG22 ' A' ' 22' ' ' ILE . . . -125.4 -139.43 5.18 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.82 64.19 2.8 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 169.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 39.2 tt0 -90.54 -57.53 2.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.796 -0.702 . . . . 0.0 111.622 -170.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' O ' HG13 ' A' ' 32' ' ' ILE . 19.7 m120 -71.64 -21.56 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.266 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.747 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.9 m -72.33 -30.08 33.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.963 -175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 21.8 ptmt -75.72 -19.93 58.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 109.879 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -78.34 -31.38 48.63 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 174.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 29' ' ' VAL . 30.5 mt -60.54 -47.47 92.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 170.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 39' ' ' PHE . 46.0 t-20 -56.66 -47.0 80.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 17.6 pt20 -66.5 -29.92 70.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.966 -178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 13.6 mm-40 -80.04 -18.28 50.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.52 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 69' ' ' ALA . 58.0 p -119.59 -72.59 0.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.72 -22.06 2.68 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 65' ' ' GLN . . . -89.65 146.49 24.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.854 0.359 . . . . 0.0 110.521 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.655 ' HB2' ' HG2' ' A' ' 60' ' ' ARG . 89.7 m-85 -83.75 107.89 16.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.39 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG12 ' HE2' ' A' ' 57' ' ' PHE . 15.5 t -89.02 100.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 177.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mt-10 -104.79 154.83 19.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.056 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.575 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 27.1 mt -83.61 109.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 175.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.571 ' HB3' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -72.18 145.9 47.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.132 0.492 . . . . 0.0 110.88 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.72 ' HD2' ' H ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -111.78 16.0 20.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.151 178.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -87.42 156.55 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.588 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.642 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 12.6 tp -110.26 143.49 28.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 51.0 Cg_endo -71.18 160.09 50.08 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.656 2.237 . . . . 0.0 111.132 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.11 -14.03 26.59 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.039 2.492 . . . . 0.0 112.569 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -80.56 -29.63 37.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.468 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.1 28.86 73.89 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.705 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -107.33 131.72 21.49 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -78.33 18.75 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.81 2.34 . . . . 0.0 113.186 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -93.6 -5.76 48.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.283 0.563 . . . . 0.0 110.274 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -133.95 118.79 18.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.777 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.36 130.02 46.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.428 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' SER . 4.2 mm? -73.6 148.13 43.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 175.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.575 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.46 142.11 48.12 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.983 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 15.5 mt -100.44 137.83 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.767 -175.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HD12 ' A' ' 73' ' ' ILE . 52.2 mt -128.53 96.18 3.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 166.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HG2' ' HB2' ' A' ' 39' ' ' PHE . 7.2 ptm85 -103.14 129.7 50.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 111.363 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.19 -149.95 18.72 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 p -94.23 157.71 37.12 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 117.157 0.479 . . . . 0.0 110.088 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -43.67 -50.79 6.77 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.397 2.731 . . . . 0.0 114.296 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -68.39 -25.6 65.14 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 99.3 mt-30 -78.46 -48.09 16.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . 51.4 mt -60.14 -50.48 80.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.185 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.21 -37.75 88.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.255 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 t-160 -64.85 -39.88 94.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.041 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.51 ' O ' HG13 ' A' ' 73' ' ' ILE . . . -70.27 -44.3 68.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 0.0 110.359 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -50.87 -46.89 60.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.748 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -63.11 -37.92 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.13 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 68' ' ' HIS . 23.9 mt -66.44 -40.36 89.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.062 0.458 . . . . 0.0 109.981 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.008 HG23 HG11 ' A' ' 21' ' ' VAL . 56.2 mt -65.56 -44.44 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.335 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 47.9 mt-10 -67.11 -16.17 64.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.221 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -87.4 -31.68 19.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.559 ' HB2' HG13 ' A' ' 21' ' ' VAL . 14.2 mmmm -66.52 -46.27 76.76 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.249 0.547 . . . . 0.0 109.805 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 20' ' ' LEU . 18.0 pt -88.75 -17.3 8.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.91 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 54.08 50.34 16.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.936 -177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.68 157.76 29.81 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.364 -178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 72.1 Cg_endo -76.32 136.01 17.34 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.436 2.091 . . . . 0.0 113.039 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 41.2 mt -103.0 142.53 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.114 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 47.2 t -95.88 127.91 39.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.201 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 13.2 Cg_exo -69.71 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.035 2.49 . . . . 0.0 111.781 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' THR . 8.0 t -119.27 161.42 18.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.237 176.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 9.6 pt-20 -64.65 118.82 9.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.203 0.525 . . . . 0.0 109.942 176.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.727 ' HB3' HG21 ' A' ' 66' ' ' ILE . 49.5 tpp -93.86 120.67 34.43 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.423 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 3.0 m -94.65 144.55 25.52 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.452 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CE1' ' HD2' ' A' ' 70' ' ' LYS . 97.4 m-85 -129.48 146.29 51.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 p -81.4 106.63 13.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.69 0.281 . . . . 0.0 110.932 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HD11 ' A' ' 22' ' ' ILE . 9.4 mm -99.54 115.11 65.89 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.322 0.582 . . . . 0.0 111.256 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HG2' ' HE2' ' A' ' 17' ' ' LYS . 95.3 Cg_exo -53.81 129.48 34.31 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.13 2.553 . . . . 0.0 112.448 173.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.1 m -60.2 -26.67 66.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.362 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.597 ' CE1' ' HG3' ' A' ' 17' ' ' LYS . 17.8 p80 -71.19 -22.49 62.02 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 121.621 -0.675 . . . . 0.0 111.066 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 16' ' ' HIS . 40.5 mtmt -96.04 13.1 28.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.648 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.809 ' HA ' HD13 ' A' ' 22' ' ' ILE . 16.5 p -76.77 16.92 0.46 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.343 0.592 . . . . 0.0 111.58 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.97 -37.09 0.73 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.148 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 21' ' ' VAL . 3.1 pp -79.02 -34.56 43.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.807 0.304 . . . . 0.0 111.762 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -34.67 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.174 175.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.937 HD11 HG21 ' A' ' 13' ' ' ILE . 1.2 mp -85.02 -65.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.388 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.71 56.89 1.38 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.491 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 40.5 74.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.465 0.744 . . . . 0.0 112.35 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.04 -41.12 2.31 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.28 50.61 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.622 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.83 -18.23 25.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.594 -0.356 . . . . 0.0 111.285 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -88.61 -30.47 19.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 0.0 110.781 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG11 ' HE2' ' A' ' 57' ' ' PHE . 34.8 m -67.0 -28.82 44.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.147 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -71.98 -27.29 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.37 . . . . 0.0 110.333 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -75.28 -31.33 60.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.986 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 29' ' ' VAL . 24.4 mt -60.15 -45.43 95.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -57.46 -51.75 68.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.837 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 8.9 pt20 -61.62 -28.91 69.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.988 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -77.85 -26.16 49.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.378 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.72 HG21 ' HA ' ' A' ' 69' ' ' ALA . 54.4 p -114.98 -75.7 0.58 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -23.93 1.79 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.14 149.47 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.841 0.353 . . . . 0.0 111.404 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.633 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 92.9 m-85 -86.95 118.55 26.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.579 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 34.8 t -95.57 99.63 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . 9.4 mm-40 -104.96 164.38 11.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.202 -173.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 4.1 mt -103.48 122.37 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 58' ' ' ILE . 63.4 m -73.36 166.46 23.15 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.809 0.814 . . . . 0.0 113.012 -168.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -117.58 1.11 12.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.466 178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -90.58 158.0 17.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.382 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' HD2' ' A' ' 47' ' ' PRO . 14.1 tp -112.17 144.68 31.28 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HD2' ' HG ' ' A' ' 46' ' ' LEU . 56.2 Cg_endo -71.73 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.362 2.041 . . . . 0.0 111.03 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.46 -3.07 3.8 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.048 2.499 . . . . 0.0 113.055 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 3.2 m-20 -95.63 -23.63 16.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.408 0.623 . . . . 0.0 110.184 176.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.68 25.01 71.51 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.143 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' OD2' ' HB3' ' A' ' 49' ' ' ASN . 9.8 m-20 -91.41 122.97 65.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.576 0.227 . . . . 0.0 110.393 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.0 0.21 6.94 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.843 2.362 . . . . 0.0 112.597 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -85.57 -7.22 58.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.97 94.55 4.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.226 0.536 . . . . 0.0 110.152 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 122.5 33.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.81 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 10' ' ' THR . 4.3 mm? -69.67 140.63 53.63 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.113 0.483 . . . . 0.0 110.47 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.707 ' CZ ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -125.0 124.85 42.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.197 176.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 41' ' ' GLU . 51.6 mt -89.02 131.98 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.353 -176.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 66' ' ' ILE . 62.6 mt -117.63 96.81 4.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HG3' ' HB2' ' A' ' 39' ' ' PHE . 8.6 ptt180 -98.86 128.79 45.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.316 0.579 . . . . 0.0 111.928 -175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.02 -166.37 36.26 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.743 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.0 m -64.71 142.4 98.52 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 117.073 0.437 . . . . 0.0 109.881 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.6 -46.68 17.2 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.856 2.371 . . . . 0.0 112.967 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 53.0 tt0 -61.24 -32.08 71.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.57 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -77.64 -37.18 50.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 109.854 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.727 HG21 ' HB3' ' A' ' 9' ' ' MET . 58.7 mt -61.73 -54.29 36.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.03 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 70' ' ' LYS . 26.4 t70 -65.98 -29.91 70.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.561 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' O ' HD12 ' A' ' 72' ' ' LEU . 6.8 t-160 -59.72 -50.13 75.03 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -62.79 -43.16 99.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.097 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 67' ' ' ASP . 28.1 tttm -53.9 -36.83 63.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.378 175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -55.21 30.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.9 mp -55.59 -29.1 58.5 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.974 HG23 HG11 ' A' ' 21' ' ' VAL . 62.0 mt -74.49 -45.51 45.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.53 -31.92 66.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.126 0.489 . . . . 0.0 110.109 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -63.8 -51.55 64.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.769 173.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' LEU . 43.3 mmtm -62.09 -45.85 91.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.258 0.551 . . . . 0.0 110.836 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG22 HD11 ' A' ' 20' ' ' LEU . 23.7 pt -89.85 -2.03 9.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.643 -173.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 40.58 49.07 2.65 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.597 1.159 . . . . 0.0 112.356 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.79 173.97 45.13 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.302 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -88.26 169.06 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.766 2.311 . . . . 0.0 112.937 -176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.4 mt -131.06 147.75 52.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.637 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 49.3 t -94.12 126.79 47.4 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' CYS . 12.9 Cg_exo -71.01 119.33 6.23 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.265 2.643 . . . . 0.0 112.238 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.532 ' O ' ' HB ' ' A' ' 10' ' ' THR . 28.2 t -123.18 149.56 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.026 176.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 1.4 pm0 -63.94 111.96 2.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.391 0.615 . . . . 0.0 110.258 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 11' ' ' PHE . 11.6 ptm -100.11 149.39 23.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.619 -173.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 84' ' ' VAL . 18.5 m -113.46 143.25 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.552 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' CE2' ' HG3' ' A' ' 9' ' ' MET . 96.6 m-85 -131.6 155.48 47.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 p -88.44 108.49 19.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.371 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 22' ' ' ILE . 24.0 mm -103.65 108.4 59.34 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.444 0.64 . . . . 0.0 110.976 177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.461 ' HB2' ' HG3' ' A' ' 17' ' ' LYS . 13.0 Cg_exo -45.95 144.42 6.0 Favored 'Trans proline' 0 N--CA 1.472 0.232 0 C-N-CA 124.007 3.138 . . . . 0.0 114.449 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.5 m -79.24 3.84 16.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.404 0.621 . . . . 0.0 110.804 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -106.5 -14.46 15.06 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.823 -0.548 . . . . 0.0 109.84 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 28.8 mtmt -103.03 3.81 36.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 175.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.995 ' HA ' HD13 ' A' ' 22' ' ' ILE . 31.4 p -69.91 1.18 4.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.842 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.11 -36.49 2.14 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.433 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 21' ' ' VAL . 2.4 pp -77.63 -34.65 53.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.86 HG11 HG23 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.24 -23.02 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 110.966 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.995 HD13 ' HA ' ' A' ' 18' ' ' CYS . 2.2 mp -107.67 -54.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.348 -171.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.83 -174.09 17.42 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -86.39 64.26 8.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 138.44 -65.75 0.54 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 161.56 56.28 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 1.5 tm-20 -89.61 -43.56 10.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.864 0.364 . . . . 0.0 110.292 -176.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' VAL . 10.1 t-20 -69.56 -40.57 76.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.967 0.413 . . . . 0.0 110.578 -175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 22' ' ' ILE . 29.2 m -63.52 -30.99 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 27' ' ' GLU . 23.1 pttp -80.6 -19.99 44.26 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.328 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' O ' ' HG2' ' A' ' 34' ' ' GLN . . . -77.16 -34.64 56.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 29' ' ' VAL . 34.1 mt -57.56 -46.1 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 21.1 t-20 -54.35 -52.68 60.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.805 176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 2.7 pt20 -63.92 -29.12 70.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -175.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 85.0 mm-40 -76.71 -28.17 55.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.432 178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' ALA . 41.2 p -110.6 -56.82 2.3 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -168.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.13 -24.94 6.18 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 148.43 22.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.204 0.526 . . . . 0.0 110.79 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HB2' ' CG ' ' A' ' 60' ' ' ARG . 81.2 m-85 -90.58 119.84 31.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.119 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 18.7 t -97.58 90.02 2.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -102.76 154.48 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.426 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.592 HG12 ' CZ ' ' A' ' 57' ' ' PHE . 7.0 mt -82.54 122.67 37.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 t -84.48 172.4 11.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.402 0.62 . . . . 0.0 111.135 -173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -127.97 16.42 6.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.35 177.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' HB2' HD12 ' A' ' 56' ' ' LEU . 84.1 mm-40 -79.9 164.99 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.384 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.29 129.59 23.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.916 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.45 158.28 53.65 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.663 2.242 . . . . 0.0 111.14 177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.38 -11.6 17.17 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.235 2.623 . . . . 0.0 113.114 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.99 -20.78 23.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 110.381 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.11 24.85 74.64 Favored Glycine 0 C--N 1.333 0.361 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.752 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.21 128.24 35.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.646 0.26 . . . . 0.0 110.747 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.53 6.52 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.933 2.422 . . . . 0.0 113.997 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -90.28 -3.32 57.86 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.826 -0.546 . . . . 0.0 110.438 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -113.18 111.14 21.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.999 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -88.34 110.14 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.285 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 45' ' ' GLN . 80.4 mt -70.13 141.05 52.73 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.596 -0.441 . . . . 0.0 109.862 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CZ ' HG12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -122.48 136.73 54.96 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.491 -178.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 8' ' ' GLU . 4.2 mt -101.66 123.13 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.955 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 66' ' ' ILE . 29.5 mt -105.75 104.3 16.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 170.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' CG ' ' HB2' ' A' ' 39' ' ' PHE . 12.2 ptm180 -109.27 141.12 42.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.097 0.475 . . . . 0.0 110.96 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.95 -153.53 25.26 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -82.19 147.9 58.42 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.12 -49.42 12.78 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.282 2.655 . . . . 0.0 113.52 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 0.7 OUTLIER -62.19 -36.34 81.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.505 -178.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.11 -41.46 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.259 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 59' ' ' ILE . 39.4 mt -57.46 -58.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.307 177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 12.6 t70 -63.7 -33.16 75.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 2.3 t-160 -62.93 -47.84 81.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' A' ' 36' ' ' THR . . . -58.13 -41.97 84.79 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.153 0.501 . . . . 0.0 110.454 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 67' ' ' ASP . 15.9 ttpp -51.28 -40.31 58.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.838 -1.073 . . . . 0.0 111.158 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 73.6 mt-30 -66.22 -47.28 74.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.36 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 68' ' ' HIS . 5.2 mp -58.39 -40.44 82.37 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.704 0.287 . . . . 0.0 110.85 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.86 HG23 HG11 ' A' ' 21' ' ' VAL . 69.5 mt -61.53 -44.1 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.01 0.433 . . . . 0.0 110.415 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 80' ' ' PRO . 49.9 mt-10 -70.5 -10.78 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.406 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -88.7 -26.1 22.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.183 0.516 . . . . 0.0 109.751 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HB2' HG13 ' A' ' 21' ' ' VAL . 72.9 mmtt -72.71 -50.64 23.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.306 0.574 . . . . 0.0 109.618 175.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.579 HG22 HD11 ' A' ' 20' ' ' LEU . 34.1 pt -84.47 -19.5 9.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.008 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 28.9 mt-10 52.4 56.98 6.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.205 -176.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.88 162.48 36.25 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.458 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.575 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 68.2 Cg_endo -75.18 141.59 26.32 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.539 2.159 . . . . 0.0 112.821 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 81' ' ' LEU . 13.7 mt -105.94 129.02 54.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.6 m -94.3 125.57 51.7 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.228 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -65.23 135.7 44.38 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.767 2.311 . . . . 0.0 112.325 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 10' ' ' THR . 56.1 t -121.28 144.14 31.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.764 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.027 178.66 . . . . . . . . 0 0 . 1 stop_ save_